TeliaSonera and Telenor announce first members of Joint Venture top management team

“We are pleased to announce Hilde Tonne, Søren Abildgaard and Dennis Kilian as the future CEO, Deputy CEO with responsibility of Consumer Business with brands, channels and marketing and CFO respectively in TeliaSonera and Telenor’s Danish joint venture. The skills, core knowledge, and areas of experience of these three people complement each other and make them a very strong top management team,” says TeliaSonera’s Executive Vice President and Head of Europe, Robert Andersson. Hilde Tonne has been a member of Telenor Group’s executive management team since 2007, and Head of Group Industrial Development since September 2011. “Hilde Tonne is a very competent and experienced leader with a strong track-record for driving change and for challenging status quo. These skills are an ideal match for joining two business units and forming a new, strong and innovative company with the ambition of challenging the Danish telco market,” says TeliaSonera’s Executive Vice President and Head of Europe Robert Andersson. Søren Abildgaard has been CEO of Telia Denmark since January 2011. “Søren Abildgaard was appointed for his insight in the industry, his commercial understanding, and operational knowledge. He has shown an ability to adapt to a fast-changing environment and translate strategic visions into action. In spite of tough times, he has created an environment in which the employees have thrived,” says Telenor’s Executive Vice President and Head of Europe Kjell-Morten Johnsen. Dennis Kilian has been CFO of Telia Denmark since March 2013. “Dennis Kilian was appointed for this position because of his firm grasp of financial fundamentals, commercial understanding and analytic skills, which has made him a key driver to the business. He has played an active role in developing and defining the overall strategy for Telia Denmark, and he has ensured that business decisions were grounded in sound financial criteria,” says Kjell-Morten Johnsen. A robust operator in the Danish market Hilde Tonne, Søren Abildgaard and Dennis Kilian will commence in the new positions once new joint venture has been established following the EU Commission’s approval of the merger which is expected during second half of 2015. Prior to that, Hilde Tonne will start as program manager 1st of August for a small Copenhagen-based team of employees from TeliaSonera and Telenor which is preparing the merger of the two Danish business units. “With the merger of Telia and Telenor we will become a robust operator in the Danish market. This will be beneficial for the customers who can look forward to valuable services and improved network experience. I also look very much forward to meet all the employees in Telia and Telenor in Denmark as we embark on the journey to establish a new joint venture in the Danish market,” says Hilde Tonne. Press meeting today at 11:30 CET in Copenhagen Telenor and TeliaSonera will host a press meeting with Hilde Tonne, Søren Abildgaard, Dennis Kilian, TeliaSonera’s Executive Vice President and Head of Europe, Robert Andersson and Telenor’s Executive Vice President and Head of Europe, Kjell-Morten Johnsen. The press meeting takes place today at 11:30 at the Hotel D’Angleterre at Kgs Nytorv in Copenhagen. Media contact: Maria Vilhardt, Communication Director in Telenor Denmark,mvil@telenor.dk, tlf: 6050 7014 David Engstrøm, Head of Press in Telia Danmark,david.jagerstedengstrom@teliasonera.com, tlf. 2827 8185Or contact the TeliaSonera press office +46 771 77 58 30, press@teliasonera.com, visit our Newsroom or follow us on Twitter @TeliaSoneraAB .

Elekta Nomination Committee’s proposed Board of Directors for the 2015 Annual General Meeting

Annika Espander Jansson has 25 years’ experience as an analyst and investor, as well as from executive positions within the financial markets and the pharmaceutical industry. She is the founder of Asperia AB and has been the CEO since June 2013. Annika Espander Jansson was born in 1964 and holds a BSc in Chemistry from Uppsala University (Sweden)/University of Michigan, Ann Arbor (US) and an MBA in International Business Management from Uppsala University. From 2010 to 2013, she was Chief of Private Banking at Handelsbanken and also Chairman of the Board of SHB Luxembourg; she has previously held executive positions at, among other companies, Catella Healthcare/Esperio AB in Stockholm and at Enskilda Securities. Annika Espander Jansson is a member of the Board of Asperia AB, Esperio AB and Symphogen AS, and she has previous Board experience from Biotage AB, Probi AB, Stille AB, Cellartis AB and SFF (Sveriges Finansanalytikers Förening) among other companies. Johan Malmqvist has extensive experience from the medical technology industry. Johan Malmqvist was born in 1961 and holds a BA from Stockholm School of Economics. From 1997 to 2015, he was president and CEO of Getinge AB. Before that, he held various positions within the Getinge group and before joining Getinge in 1990, Johan Malmqvist held several positions within the Electrolux group. From 1997 to 2007, Johan Malmqvist was a member of the Board of Getinge AB. In accordance with the Nomination Committee’s proposal, the number of Board members will thus be nine. The Nomination Committee’s complete proposal for resolution at the Annual General Meeting, to be held on September 1, 2015, will be available on the company’s website and will be published in the notice of the Annual General Meeting. The Nomination Committee, prior to the 2015 Annual General Meeting, comprises the following members: Laurent Leksell (Chairman), appointed by the Leksell family for the family’s direct and indirect holdings and in his capacity as Chairman of the Board, Åsa Nisell, appointed by Swedbank Robur Funds, Jens Barnevik, appointed by Didner & Gerge Funds, Anders Oscarsson, appointed by AMF and AMF Funds, and Ossian Ekdahl, appointed by Första AP-fonden. Caroline Leksell Cooke has been co-opted to the Nomination Committee. # # # For further information, please contact:Gert van Santen, Group Vice President Corporate Communications, Elekta ABTel: +31 653 561 242, e-mail: gert.vansanten@elekta.comTime zone: CET: Central European Time Johan Andersson, Director, Investor Relations, Elekta ABTel: +46 702 100 451, e-mail: johan.andersson@elekta.comTime zone: CET: Central European TimeThe above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on July 1, 2015.About ElektaElekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

SEQR gets its first MTL in US

The company has during the past years structured several strategic partnerships in US, while integrating its platform to the US Banking ACH system. This allows the company to offer its merchants and users a significantly enhanced shopping experience, driven by increased transaction speed, increased loyalty, lowered fraud and significantly lower cost associated with the transaction. Now it’s time for the next step in the roll-out through obtaining the first MTL. “It’s a great step that we have the first MTL in place as the MTLs allow us to offer the full range of features also on the US market. For example MyShop which enables the user to create and distribute their own classified ads in addition to use SEQR P2P services, which works both nationally and internationally, and simplifies the everyday life of millions of Americans” says Peter Fredell, CEO of Seamless. “We are excited together with our partners and clients to further strenghtening our product offering in US. This important step in our expansion, positions ourselves as a true leader in the Mobile Payment Solution space,” says Daniel Bessmert, GM of SEQR USA. During the past year Seamless prepared and submitted MTL applications for a majority of the states. Now, with the first MTL being approved the expectations are that the rest of them will be approved within the next coming twelve months. For more information: Daniel Bessmert, General Manager SEQR USA +1 718 8792169, daniel.bessmert@seqr.com Peter Fredell, CEO Seamless +46 8 564 878 00, peter.fredell@seamless.se This information is such information that Seamless Distribution AB (publ) is required to disclose pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instrument Trading Act. The information was released for publication on 01 July 2015 at 07.50 am (CET). ABOUT SEQR, by SeamlessSEQR (se·cure) is Europe’s most used mobile payment solution in stores and online. SEQR enables anybody with a smartphone to pay in stores, at restaurants, parking lots and online, transfer money at no charge, connect loyalty programs, store receipts digitally and receive offers and promotions directly through one mobile app. Through the SEQR app, the user simply scans or taps a QR-code/NFC at check-out and approves the purchase by entering a PIN code. Fast, smooth and safe, SEQR’s payment solution enables merchants to lower interchange fees significantly compared to those charged by traditional card companies. SEQR’s unique transaction platform has been developed by Seamless, one of the world’s largest suppliers of payment systems for mobile phones. Founded in 2001 and active in 26 countries, Seamless handles more than 3,1 billion transactions annually through 525 000 active sales outlets. 6 200 merchants have chosen SEQR including the largest grocery chains, fast food chains and national retailer chains in the markets where SEQR is established. Currently SEQR is established in Sweden, Finland, Romania, Belgium, Portugal, Netherlands, Germany, Spain, France, Italy, UK and US. In 2013, SEQR won the Mobile Money Global Award for Best Mobile Money Deployment in Europe. Seamless is traded on Nasdaq OMX Stockholm, under the SEAM ticker. www.seqr.com

MTG invests in world’s largest esports company ESL

This investment is in line with MTG’s strategy to complement its linear and on-demand video entertainment services by investing in fast growing digital companies with relevant and scalable communities and content. It also reflects MTG’s long and successful track record of building TV and online audiences for leading international sports brands. Furthermore, MTG is already present in the esports market with its Viagame.com platform and has broadcast coverage of esports on its TV channels. The 74% stake is being acquired from financial investors and the company’s founders for EUR 78 million in cash. The founders and management will retain the remaining 26% and continue in their current positions. Closing of the transaction is subject to local regulatory approvals, and MTG will report approximately SEK 20 million of costs related to this transaction in its second quarter results. ESL’s online leagues and tournaments, such as ESL One and Intel® Extreme Masters, are among the biggest in the world, and have attracted more than 70 million unique online viewers over the past 12 months.  They feature top international teams and star players competing in the most popular games. ESL’s 16,000 hours of live content are made available on Twitch (the biggest online games streaming platform), YouTube and other platforms. See here (https://www.youtube.com/watch?v=ylp2p0pipQo) and here (https://www.youtube.com/watch?v=MDmyfOmIip4) for video links. Two thirds of esports viewers are between 10 and 35 years old, and 58% of Twitch users already watch more than 20 hours of esports every week. With almost 50% of monthly views, video gaming is also the most watched YouTube category in MTG’s territories.     Working closely with all the major games publishers and developers, the majority of Turtle’s revenues come from advertising and sponsorship for its events, online league operations and broadcast media rights. Turtle also sells merchandise, event tickets and subscriptions. Turtle is expected to grow its revenues by 50% to approximately EUR 50 million in 2015, and report an EBIT profit. Established in 2000 and based in Cologne (Germany), Turtle employs over 300 people in 9 offices around the world. “At MTG, we love sports and we love sports fans. Our TV channels and platforms are home to the world’s leading sports brands, and are watched by typically young audiences. Esports is fast becoming one of the most watched and passionately followed global sports categories amongst younger audiences. There are now almost as many gamers in the world as traditional sports fans, and esports was almost as big as ice hockey in 2014 in terms of number of enthusiasts. However, the average revenue generated per esports enthusiast in 2014 was just over USD 2, compared to USD 56 for traditional sports fans, so this global phenomenon has tremendous potential. This investment is a key milestone in our digital development. We look forward to working with the talented Turtle team to grow the global esports community, and to make this exciting content even more broadly available online and on TV.” Jørgen Madsen Lindemann, MTG President and CEO “When we founded ESL 15 years ago, our goal was to bring esports to fans all around the world and establish it as a global sport.  Today, esports enjoys worldwide recognition and now, together with MTG, it is time to take esports to the next level. We are excited to partner with MTG, who share our enthusiasm for the sport and bring an entrepreneurial commitment to help make this dream come true.  MTG’s extensive operational network in over 100 countries and broadcast sports experience will help us bring ESL and esports to many more places around the world, while allowing us to continue expanding on strong, strategic local partnerships. The ESL leadership team could not be more excited about accelerating the development of the entire esports industry together with MTG for years to come.” Ralf Reichert, Managing Director of Turtle Entertainment Presentation materials and photos will be available from www.mtg.com and MTG will host an open conference call today at 09.00 CET. To join the call, please dial: · Sweden: +46 (0)8 5065 3937 · International: +44 (0) 20 3427 1908 · US: +1 646 254 3367 · PIN code: 9285753 ****

Scania signs transparency and anti-corruption declaration with Colombia

The Swedish Corporate Social Responsibility (CSR) Network has been established by the Swedish Embassy in Colombia and developed with the South American country’s Secretariat of Transparency, part of the Presidency of the Republic. Sweden is the first country in Colombia to make this kind of pact. The vision of Sweden within the framework of sustainable business is that all companies should create value and perform operations that promote sustainable development within, for example, economic, social and environmental areas. The Swedish Embassy in Colombia is supporting Swedish companies on these issues and leading a network of CSR with a particular focus on four areas: human rights, labour rights, environment and anti-corruption. The statement of transparency and anti-corruption has guidelines and standards for how companies operate. The guidelines include zero tolerance for corruption, anti-corruption initiatives supported by Swedish companies and a commitment from them to strengthen and implement programs and tools against corruption. “Scania has always had a focus on transparency in all its operations and that is why we immediately supported this declaration,” says Benoit Tanguy, Managing director of Scania Colombia. Scania is becoming an increasingly global company and is developing business in new global markets. A key challenge is to ensure that the same high standards and processes are in place wherever the company operates. “Scania needs to set a good example of corporate responsibility wherever we operate in the world. I think it is very positive that Scania works in partnership with the Embassy and others with urgent areas like these”, says Andreas Follér, Sustainability Manager at Scania. For further information, please contact: Andreas Follér, Sustainability Manager, Scania tel.+46 8 553 700 34.

CybAero delivers first helicopter system to Chinese AVIC

CybAero signed an eight-year framework agreement with the Aviation Industry Corporation of China (AVIC) in July 2014 for 70 helicopter systems at a value of approximately SEK 700–800 million. A demonstration system was also ordered in addition to the 70 systems, and it is now approved for delivery. An export license was received from the Swedish Agency for Non-Proliferation and Export Controls (ISP) on June 26. Factory testing and test flightsFactory testing and test flights were conducted in the latter half of June in collaboration with representatives of AVIC and CybAero's distributor ACC. The helicopter system was approved by the client today and will be delivered to China in July. The tests have been highly extensive, some of them were conducted using the client's own equipment, and they were conducted in various environments, including CybAero's new test center. “Today we completed an intensive test period with a satisfied client," says Mikael Hult, CEO CybAero. “We are extremely positive about the results we have achieved during this week's tests. The system CybAero is delivering meets our requirements and will be commissioned as early as August. The helicopter will be used in demonstrations for potential clients and other stakeholders," says Bing Leng, Marketing and Sales Director for ACC Group AB and Richard Su, General Manager for China Aviation Industry Supply and Marketing Corporation. Delivery to distributorCybAero received a call-off for the first five systems under the framework agreement in March 2015. The systems are in production and will be delivered to ACC in fall 2015. “We have now initiated the delivery phase of our largest order ever, which feels extremely exciting. CybAero is now taking the step from being a development company to becoming a production company," Mikael Hult concludes.

Quarterly Report III 14/15

Reporting period, March 1, 2015 – May 31, 2015 · Net result amounted to MSEK -7.3 (-3.6) · Net result per share amounted to SEK -0.4 (-0.2) · Cash flow from operating activities amounted to MSEK -4.8 (-4.1) · Liquid assets and short term investments amounted at the end of the period to MSEK 34.2 (38.8) First nine months, September 1, 2014 – May 31, 2015 · Net result amounted to MSEK -17.2 (-12.8) · Result per share amounted to SEK -0.9 (-0.6) · Cash flow from operating activities amounted to MSEK -14.6 (-24.1) Significant events during the reporting period · DIAMYD®/GABA. First patient included in US Diamyd® and GABA diabetes study · DiAPREV-IT 2. New study started with the diabetes vaccine Diamyd® to stop type 1 diabetes in children · DIABGAD. Diamyd Medical announced that immunological results from a study with Diamyd® were to be presented in April · Diamyd Medical received SEK 15 million in a direct issue · Diamyd Medical announced that the Company contributes to JDRF initiative to increase understanding of type 1 diabetes · DIABGAD. Immunological markers affected after six months in a first combination study with the diabetes vaccine Diamyd® · Diamyd Medical increased investment in stem cell activity · EDCR started – first patient included in new study combining the diabetes vaccine Diamyd® with etanercept · Diamyd Medical increased investment in Companion Medical CEO commentsDiamyd Medical tackles autoimmune type 1 diabetes on three fronts: drug development, stem cell technology and medical devices. During the last quarter, the Company has advanced its positions in all of these areas. In addition to efforts to identify partners for the diabetes vaccine Diamyd®, the following were also noteworthy: a) three new studies with the diabetes vaccine Diamyd® (DiAPREV-IT 2 , Diamyd®/GABA, and EDCR IIa) recruited their first patients; b) Diamyd®+vitamin D+ibuprofen has been well tolerated during the first six months’ treatment as part of the DIABGAD study (immunological results); c) additional shares were acquired in the stem cell company Cellaviva, and; d) more shares were purchased in the medical devices company Companion Medical. In addition, a private placement brought in SEK 15 million to Diamyd Medical. Diamyd Medical sees many values in using resources to try to extend the life of and improve quality of life for people with type 1 diabetes. Type 1 diabetes is a life-long autoimmune disease, where the body’s own immune system breaks down the cells in the body that produce the vital hormone insulin. Each day, the blood sugar level is checked with frequent measurements and, each day, insulin must be added through injections or a pump to sustain life. Still, these patients risk severe complications from the disease, both in the short term and the long term. Type 1 diabetes is estimated to cost around SEK 100 billion annually in the US alone and, currently, there is no approved treatment in the market that can interrupt or prevent the autoimmune process. All things considered, this makes diabetes one of the greatest opportunities of our age, from both a humanitarian and a business perspective. New products in the diabetes field that improve conditions for patients have enormous financial potential. The diabetes vaccine Diamyd® is, to the Company’s knowledge, ”first in class” in terms of antigen-based therapeutics being developed for type 1 diabetes. Diamyd® has demonstrated a good safety profile in studies with more than 1,000 participants. In a European phase III study conducted in nine countries with 334 newly diagnosed children, Diamyd® showed an efficacy of 16 percent (p=0.10) with regard to preserving the body’s capacity to produce insulin. Even small improvements in the ability to preserve the body’s ability to produce insulin are considered significant advances in protecting against complications later in life. The Company’s strategy is now, in various smaller studies, to combine the diabetes vaccine Diamyd® with other substances and devices with market approval with the aim of identifying a treatment that synergistically strengthens the efficacy of the diabetes vaccine. Three such studies are currently ongoing in which Diamyd® is being combined with substances such as GABA, etanercept, ibuprofen and vitamin D for children recently diagnosed with type 1 diabetes. In a fourth study with adult patients, Diamyd® is administered directly into lymph nodes, again in combination with treatment with vitamin D. Furthermore, two studies are ongoing with Diamyd® to evaluate whether it can prevent or delay type 1 diabetes in children who are at high risk of developing the disease. Stem cell technology is advancing at a rapid pace. The Company’s commitment in this area builds on the vision of a combination treatment with tolerance induction for the insulin-producing beta cells, paired with treatment with autologous differentiated stem cells to replace lost beta cell mass that could finally mean a cure for type 1 diabetes. Diamyd Medical now owns 39 percent of the stem cell company Cellaviva and is open to additional collaborative undertakings in this and other areas to win the fight against type 1 diabetes. Thank you for your interest. Stockholm, July 1, 2015Anders Essen-MöllerPresident and CEO Diamyd Medical AB (publ) Significant events during the reporting period First patient included in US Diamyd® and GABA diabetes studyThe first patient was randomized and dosed in a pioneering study combining the diabetes vaccine Diamyd® with GABA in children with new onset type 1 diabetes. The aim of the combination therapy is to preserve the body’s residual capacity to produce insulin. New study started with the diabetes vaccine Diamyd® to stop type 1 diabetes in childrenDiAPREV-IT 2 started. In the new study, the second of its kind, the diabetes vaccine Diamyd® is tested to prevent or delay the onset of type 1 diabetes in children at very high risk of presenting with the disease. Immunological results from a study with Diamyd® in AprilDiamyd Medical announced that immunological results from DIABGAD were to be presented at an international diabetes congress (IDS) in Munich on April 12 to 16, 2015. Diamyd Medical received SEK 15 million in a direct issueDiamyd Medical accepted an offer from a group of international institutional investors, previously not shareholders in Diamyd Medical, to issue 2,000,000 new B shares in a direct placement at 7.50 SEK per share. Total proceeds to the Company amounted to SEK 15 million. Diamyd Medical announced that the Company contributes to JDRF initiative to increase understanding of type 1 diabetesDiamyd Medical joined a research initiative aimed at increasing the understanding of the natural progression of type 1 diabetes in order to transform and accelerate drug development for the disease. Diamyd Medical will contribute data from the control (placebo) arm of its European Phase III study with the diabetes vaccine Diamyd®. The data will be made available to the research community in an open access database together with similar data from other late stage studies in type 1 diabetes. Immunological markers affected after six months in a first combination study with the diabetes vaccine Diamyd®A first evaluation, after six months, of immunological markers in DIABGAD was performed. Both anti-inflammatory and inflammatory immunological markers are affected by the Diamyd® treatment. The safety profile is good, with regards to the combination of Diamyd® with vitamin D and ibuprofen, as well as the combination of single or double doses of Diamyd® with vitamin D. Metabolic results, such as the treatment’s effect on the ability to produce insulin, are expected to be ready for presentation by end of 2015 when all patients have completed their 15-month follow-up. Diamyd Medical increased investment in stem cell activityDiamyd Medical invested an additional SEK 0.8 million in Cellaviva AB, Sweden's first commercial biobank for stem cells. EDCR started – first patient included in new study combining the diabetes vaccine Diamyd® with etanerceptThe first patient was included in a new study, EDCR, in which the diabetes vaccine Diamyd® is combined with two other approved agents, the immunosuppressive drug etanercept and vitamin D, with the aim to evaluate the safety of the combination treatment as well as its impact on the immune system in children and adolescents newly diagnosed with type 1 diabetes. With the start of EDCR a total of six clinical studies are now ongoing where alternative approaches with Diamyd® are being tested, either in combination with other agents or by administering the diabetes vaccine at an earlier stage in the disease process, prior to type 1 diabetes diagnosis. Diamyd Medical increased investment in Companion MedicalDiamyd Medical increased its investment in Companion Medical by USD 150,000. This was done in connection with a financing transaction in which Eli Lilly invested USD 3 million in Companion. About the diabetes vaccine Diamyd® Type 1 diabetes is a devastating disease which requires daily treatment with insulin to sustain life. The importance of finding a cure should not be underestimated. Diamyd® is considered to be the world’s furthest developed Antigen Based Therapy (ABT) for treating the disease. Diamyd® has been used in clinical studies with more than 1,000 patients and has shown a good safety profile. In a European Phase III study Diamyd® showed good clinical effect in several subgroups, and a limited overall 16% efficacy (p=0.10) in preserving endogenous insulin secretion. To enhance the overall effect, combination treatments with Diamyd® and other approved agents are being pursued. Diamyd® is easy to administer in any clinical setting. The potential annual market is estimated to several billion dollars. Six researcher-initiated clinical studies with Diamyd® in different treatment regimens are ongoing: · DIABGAD-1 – COMBINING DIAMYD® WITH IBUPROFEN AND VITAMIN DA placebo-controlled study, where Diamyd® is being tested in combination with ibuprofen and vitamin D. The study comprises a total of 64 patients between the ages of 10 and 18 recently diagnosed with type 1 diabetes, and will continue for a total of 30 months. The aim of the combination treatment is to preserve the body’s residual capacity to produce insulin. The study runs at nine clinics in Sweden and is led by Professor Johnny Ludvigsson at Linköping University, Sweden. 15 month results from the study are due in the fourth quarter of 2015. · DIAGNODE –DIAMYD® IN LYMPH GLANDS IN COMBINATION WITH VITAMIN DAn open label study, where Diamyd® is administered directly into lymph nodes in combination with treatment with vitamin D. The study comprises five patients between the ages of 18 and 30 newly diagnosed with type 1 diabetes, and will continue for a total of 30 months. The aim of the study is to evaluate the safety of the combination treatment and the effect on the immune system and the patients’ insulin producing capacity. The study is led by Professor Johnny Ludvigsson at Linköping University, Sweden. The first patient was included in the study in February 2015. · DIAMYD®/GABA – COMBINING DIAMYD® WITH GABAA placebo-controlled study, where Diamyd® is being tested in combination with GABA. The study comprises 75 patients between the ages of 4 and 18 recently diagnosed with type 1 diabetes, and will continue for a total of 12 months. The aim of the combination treatment is to preserve the body’s residual capacity to produce insulin. The study is led by Professor Kenneth McCormick at the University of Alabama at Birmingham, USA. The first patient was included in the study in March 2015. · EDCR IIa – COMBINING DIAMYD® WITH ETANERCEPT AND VITAMIN DAn open label study, where Diamyd® is combined with etanercept and vitamin D. The study comprises 20 patients between the ages of 8 and 18 who have been newly diagnosed with type 1 diabetes, and will continue for a total of 30 months. The aim of the study is to evaluate the safety of the combination treatment and the effect on the immune system and the patients’ insulin producing capacity. The study is led by Professor Johnny Ludvigsson at Linköping University, Sweden. The first patient was included in May 2015. · DiAPREV-IT 1– DIAMYD®A placebo-controlled study, where Diamyd® is being tested in children at high risk of developing type 1 diabetes, meaning that they have been found to have an ongoing autoimmune process but do not yet have any clinical symptoms of diabetes. A total of 50 participants from the age of four have been enrolled in the study, which will last for five years. The aim of the study is to evaluate whether Diamyd® can delay or prevent the participants from presenting with type 1 diabetes. The study is led by Dr. Helena Elding Larsson at Lund University, Sweden. Five year results are expected at the end of 2016. · DiAPREV-IT 2 – COMBINING DIAMYD® WITH VITAMIN DA placebo-controlled study, where Diamyd® is being tested in combination with vitamin D in children at high risk of developing type 1 diabetes, meaning that they have been found to have an ongoing autoimmune process but do not yet have any clinical symptoms of diabetes. A total of 80 participants between the ages of 4 and 18 will be enrolled in the study, which will last for five years. The aim of the study is to evaluate whether Diamyd® can delay or prevent the participants from presenting with type 1 diabetes. The study is led by Dr. Helena Elding Larsson at Lund University, Sweden. The first patient was included in March 2015 *** To read the complete report, please visit www.diamyd.com, or see attached PDF ***.

Opcon: signs share purchase agreement concerning the sale of compressor and Waste Heat Recovery business for SEK 400 million

Opcon, the energy and environmental technology Group, has signed a share purchase agreement concerning the sale of the Group’s business in compressor technology and Waste Heat Recovery. The deal includes the newly formed holding company, Opcon Compressor Technology AB, and the subsidiaries Svenska Rotor Maskiner AB, Opcon Energy System AB as well as 48.9796% of the shares in the joint venture in China, Fujian Opcon Energy Technology Co. Ltd. The acquisition also includes all the intellectual property rights relating to compressor technology and Opcon Powerbox. The Opcon brand will also be transferred but will continue to be used by the Opcon Group during a transition period. The purchase amount, following the performance of due diligence based on the accounts dated 31 March 2015, is set at SEK 400 million. 15% of the purchase amount shall be paid in cash within 20 days of the agreement coming into effect through the approval given by an extra general meeting of Opcon shareholders and by the investment committee of the investment company that controls the buyer. The remaining 85% of the purchase amount shall be paid in cash upon the closing of the deal, which is expected to be 30 September 2015, when the buyer will gain ownership of the transferred shares. The share purchase agreement has been signed with the Chinese investment fund, Shanghai XingXueKang Investment Partnership, which is controlled by the Chinese investment company, Fujian XingXueXuanYuan Capital Management Co., Ltd. This investment company was set up by Fujian Snowman Co. Ltd., which has a 29% stake, and other Chinese investors. The agreement is conditional on acceptance being given by an extra meeting of Opcon AB shareholders and on acceptance by the investment committee of Fujian XingXueXuanYuan Capital Management Co. Ltd.Snowman is Opcon’s largest regular customer and the second largest owner of Opcon, controlling 17% of the capital and voting rights.Svenska Rotor Maskiner AB (SRM) was founded in 1908 as AB Ljungströms Ångturbin and is the inventor of the screw compressor, among other achievements. SRM is Opcon’s center-of-excellence for compressor technology and holds all intellectual property related to the compressor technology that has been developed by it since the 1930s. Opcon Energy Systems AB is the operating company in the compressor and waste heat recovery part of Opcon’s business and the owner of the Opcon Powerbox technology for generating electricity from low-temperature waste heat. The companies have around 45 employees and had a joint sales turnover of around SEK 71 million in 2014 with an operating profit EBITDA of around SEK 9 million.- “I am proud and happy that we have been able to finish this agreement within the time we set ourselves. There is an enormous amount of work behind this from all involved. This deal is good for Opcon and Opcon’s shareholders. Opcon will receive SEK 400 million in cash from the sale, which will strengthen the company’s financial position considerably. The remaining part of the Group will have around 100 employees in Sweden, Germany and the UK with a strong focus on bioenergy. As a result we have initiated a full review of Opcon’s organizational structure and strategy,” says Rolf Hasselström, President and CEO of Opcon.- “SRM is a part of Swedish industrial history. That SRM and Opcon Energy Systems along with our new cutting-edge energy- and environmental technology Opcon Powerbox are now being sold to China is something of a sign of our times. The majority of our sales turnover in these companies already have Chinese final customers, and we see how the Chinese are now investing heavily in industry, renewable energy and increased energy efficiency. We are convinced that this agreement will be positive for the companies and their employees and we feel confident that this will give SRM and Opcon Energy Systems the increased resources and contacts needed in the fast-growing Chinese market in order to develop, grow and to employ even more people also in Sweden” says Rolf Hasselström, President and CEO of Opcon.Advisors to Opcon have been Awapatent AB, Hamilton Advokatbyrå and Erik Penser Bankaktiebolag. Legal advisor for the Buyer has been Advokatfirman Vinge.For further information, please contact:Niklas Johansson, vice president, Investor Relations, tel. 08-466 45 11, 070-592 54 53Opcon AB, Box 15085, 104 65 Stockholm, SwedenTel. 08-466 45 00, fax 08-716 76 61e-mail: info@opcon.sewww.opcon.se The Opcon Group Opcon is an energy and environmental technology Group that develops, produces and markets systems and products for eco-friendly, efficient and resource-effective use of energy. Opcon has activities in Sweden, Germany and the UK. There are around 140 employees. The company’s shares are listed on Nasdaq OMX Stockholm. The Group comprises one business area: Renewable Energy focuses on the following areas: compressor technology, electricity generation based on waste heat, bioenergy-powered heating and CHP plants, pellets plants, handling systems for biomass, sludge, recycling industry and natural gas, industrial cooling, flue gas condensation, treatment of flue gases and air systems for fuel cells. This information was submitted for publication on Wednesday 1 July 2015, at around 08:30 (CET).

Finnair has received IATA’s PHARMA certificate as the first airline in the world

Finnair Cargo has passed IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics program (CEIV Pharma). Finnair joined the program under the successful Brussels Airport CEIV Pharma Community approach, as Brussels is Finnair Cargo's 2nd hub. Pharmaceuticals (e.g. vaccines, biotech medicines) are among the most delicate products transported as air cargo, and therefore, it is essential to ensure their transport follows a global standard and strict temperature control guidelines.  “We are committed to be at the forefront in the fast growing Pharma transport segment and provide excellent service to our customers. Therefore, we are honored to be the first carrier in the world to complete the IATA pharmaceutical certification process ", says Juha Järvinen, Finnair’s Chief Commercial Officer. The certificate was presented to Finnair Cargo in conjunction of the laying of the cornerstone of Finnair’s new cargo terminal, the COOL Nordic Cargo (CNC) hub. The new state-of-the-art terminal will feature separate temperature controlled areas for the handling of Pharmaceuticals as well as other perishables foodstuffs. “We are delighted to recognize FINNAIR and its HEL station as CEIV Pharma Certified – the first airline to complete this process. From its state-of-the-art facility, excellent quality management system, well-trained workforce, and certifications, FINNAIR has raised the bar high for the rest to follow. I congratulate FINNAIR on this achievement”, said Rafael Schvartzman, IATA’s Regional Vice President for Europe. Further information on the CEIV Pharma program: http://www.iata.org/ceiv-pharma Photos from the laying of the cornerstone can be requested from cargo.comms@finnair.com. Finnair Cargo Finnair is the largest Nordic cargo carrier, transporting nearly 150,000/approximately 149,000 tons of freight and mail annually, with cargo logistics hubs in Helsinki and Brussels as well as an extensive GSA network in over 40 countries. Specialized in air cargo traffic between Europe and Asia, Finnair Cargo connects 15 cities in Asia with more than 60 destinations in Europe and North America. Cool to care - Finnair Cargo’s Nordic Pharma Chain offers reliable shipping for fragile healthcare products that require temperature controlled transport.

Oil and gas discovery at Gina Krog East 3

Det norske oljeselskap ASA, partner in the Gina Krog Unit in the North Sea, announces that drilling of exploration well 15/6-13 with two sidetracks, 15/6-13 A and 15/6-13 B exploring the East 3 segment is about to be completed. The wells encountered gas and oil in both the Hugin and Sleipner formations. The total gas column in the Hugin formation is estimated to be approximately 150 meters and the oil column is evaluated to be approximately 150 meters. This results in a total hydrocarbon column height of approximately 300 meters, with good reservoir properties. An extensive data acquisition program was carried out in the reservoir sections. Initial analysis indicates the wells have proven in the range of 6 – 13 million barrels of oil equivalent recoverable. Additional volumes in the Sleipner formation will be further evaluated by the Gina Krog Unit. Further studies will be undertaken to evaluate if the discovery can be produced as part of a future area development solution. Det norske holds a 3.3 percent working interest in the Gina Krog Unit. Statoil Petroleum AS is the operator with 58.7 percent working interest. Total E&P Norge AS is partner with 30 percent working interest and PGNiG Upstream International AS is partner with 8 percent working interest. For more information, please find the release from the Norwegian Petroleum Directorate here (http://npd.no/en/news/Exploration-drilling-results/2015/156-13-156-13-A-and-156-13-B/).

Ideal Cures becomes a Trendsetter - Receives EXCiPACT™ Certification for all its three Manufacturing sites

IDEAL CURES PVT. LTD. is delighted to announce that it has received third EXCiPACT™ certificate for its manufacturing site located at Vasai. The plant at Vasai is the main manufacturing facility of the company and has received EXCiPACT™ certification for Film Coating Materials (INSTACOAT™, INSTANUTE™, INSTASPRAY™, and INSTAMASK™) and Extended Cooling Boosters (ECOCOOL™). With receipt of this third certificate all manufacturing plants of Ideal Cures located in India at Vasai, Jammu and Khambhat are EXCiPACT™ certified. Speaking about the news, Mr. Suresh Pareek, Managing Director of the Company said “I am very happy and proud to say that Ideal Cures becomes a trendsetter by being the first Indian company to receive EXCiPACT™ certification for all its manufacturing plants. The receipt of EXCiPACT™ certificate indicates that GMP standards are followed for manufacturing of high quality excipients. Many other Indian excipient manufacturers will follow this trend of acquiring EXCiPACT™ certification, causing overall improvement in manufacturing standards and capability of India which will eventually contribute to the ‘Make in India’ dream of our Prime Minister Shri. Narendra Modi.” He further added, “All this has been made possible because of the dedication and hard work of our team. The EXCiPACT™ certification has set a bar for us to provide best quality products and technical services to our customers worldwide.” EU, U.S. and pharmaceutical excipient regulations of other countries, currently require drug manufacturers to either do their own audits or rely on 3rdparty audits of all of their starting material suppliers to demonstrate GMP and/or GDP compliance. EXCiPACT™ is a high quality, voluntary international scheme that provides independent third party certification to manufacturers, suppliers and distributors of pharmaceutical excipients worldwide. All EXCiPACT™ approved certifying bodies and their auditors have had to undergo a rigorous assessment process in order to become EXCiPACT™ Registered and to provide certification. Since the certification is international in nature, in the long run it will be a boon to the excipient manufacturers and suppliers. IDEAL CURES surely hopes to gain added trust of customers with the addition of third EXCiPACT™ certification in its basket of achievements. 

Press release: Transfer of warrants in Nexam Chemical´s incentive program has been completed.

At the Annual General Meeting of Nexam Chemical Holding AB (publ) (“Nexam Chemical”) on 12th May 2015, it was resolved to implement an incentive program in which a maximum of 646,000 warrants could be transferred to senior executives and key personnel within the Nexam Chemical Group. A total of 646,000 warrants has now been transferred whereof 120 000 warrants have been transferred to CEO Anders Spetz. In accordance with the resolution of the Annual General Meeting, the subscription price upon exercise of the warrants has been set to 13.00 SEK per share. This corresponds to 150 percent of the volume weighted average last closing price for the Company’s share, on Nasdaq OMX First North, during the period 13th May – 26th May 2015. The price for the warrant has been calculated at market value according to the “Black Scholes” formula and amounts to 0.76 SEK per warrant. In case all 2,674,625 warrants outstanding in the group are exercised, the aggregate dilution will amount to approx. 4.9 percent. For full terms and conditions of the incentive program, please see the resolution (http://www.nexamchemical.com/Documents/Arsstamma-2015/F%c3%b6rslag%20till%20incitamentsprogram%202015%20Final.pdf) (in Swedish) from the Annual General Meeting. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Lennart Holm, Chairman of the Board, +46-706 30 85 62, lennart.holm@nexamchemical.com

Telenor Sweden relocates to newly built office in Råsunda

All of Telenor Sweden’s employees, whose workplaces are currently located near Slussen, will move to a newly built, environmentally certified office in the new Hörnan 1 block. The office will be located near the Frösundaleden highway, with excellent public transport links, including light railway, underground and bus service, as well as airport shuttles to Arlanda and Bromma Airports. The office will also be within walking distance of Solna Centrum.  “It feels great to be moving to a new Stockholm office. The new premises will allow us to create a modern, flexible office environment that promotes collaboration, creativity and efficiency,” says Patrik Hofbauer, CEO of Telenor Sweden. Telenor’s lease will be a Green Lease, which entails that both parties will aim to identify operating solutions that are resource-efficient and environmentally smart, at the same time as the building will be environmentally certified according to the BREEAM Very Good standard. “Through this transaction and our other aggressive project acquisitions in the first half of the year, we have paved the way for the future development of our areas and we see excellent potential to continue developing our project portfolio,” concludes Christian Hermelin, CEO of Fabege.   Fabege intends to acquire and develop the property, which is currently jointly owned by PEAB.  Following the signing of the lease, slightly more than 60 per cent of the project property is now leased. – “We are delighted with this lease and are pleased to know that Telenor Sweden shares our vision for the new Råsunda. This exciting project is breathing new life into an old city district in Solna,” says Klaus Hansen Vikström, Deputy CEO and Director of Business Development at Fabege. Fabege AB (publ)

HANZA acquires Metalliset Group and carries out a rights issue, bringing 50 MSEK to HANZA

Metalliset provides high quality mechanical manufacturing and has approx. 500 employees in Finland, Estonia, the Czech Republic and China. The customers are larger, well-known Nordic companies. Through the acquisition HANZA creates a group with a turnover of about SEK 1.5 billion and a profitability which is considerably higher than the current level, both in absolute and relative figures. Through the acquisition, the number of manufacturing technologies provided in HANZA’s all-you-need-is-one™ and MIG™ concepts is increased and HANZA’s geographical presence is strengthened. The total purchase price amounts to approx. 70 MSEK and consist of one part cash and one part newly issued shares in HANZA to be paid at completion, as well as an earn-out based on the financial outcome 2015 of Metalliset group . The earn-out cannot exceed 1 MEUR. In order to finance the acquisition and capitalize the new group, the board of directors of HANZA has resolved, subject to the approval by the general meeting, on a rights issue bringing 50 MSEK to HANZA prior to transaction costs. The board of directors intends to convene an extraordinary general meeting of shareholders within shortly where the board of directors intends to propose that the general meeting approves of the board of directors’ decision on the rights issue.  In addition, the board of directors intends to propose that the general meeting authorises the board of directors to resolve on a directed issue of new shares corresponding to approx. 15 % of the outstanding shares in HANZA, after the rights issue and the aforementioned directed issue of new shares. The share issue shall be directed towards the current shareholders of Metalliset as a part of the agreed purchase price. Payment for the new shares in HANZA shall be made by way of set-off against the claim for payment of a part of the purchase price for the shares of Metalliset in accordance with the share purchase agreement entered into between the Company and the current shareholders of Metalliset. The completion of the acquisition of Metalliset is preconditioned upon that the general meeting resolves in accordance with the board of directors’ proposal as described above and that the necessary approvals for the completion of the acquisition are obtained from the Estonian competition authority. “Metalliset is a very well-managed enterprise and the acquisition is an important step in the development of HANZA”, says Erik Stenfors, CEO of HANZA. “Our opinion is that there are great synergies to be obtained in relation to our existing mechanical division and the direction management of Metalliset has a market leading competence within the industry field and will work actively in the integration phase. Through the acquisition we will create a profitable and financially stable group, with the most modern business model on the market.” “We are happy with this deal which provides great opportunities for the Metalliset group going forward”, says Matti Hirvonen, CEO of Metalliset. “HANZA’s developed business model towards complete manufacturing and manufacturing solutions creates new possibilities for Metalliset’s customers”. About the rights issue On 1 July 2015 the board of directors of HANZA resolved, subject to the approval by the general meeting, on a rights issue of not more than 8 574 411 new shares in HANZA. Upon full subscription, the rights issue will bring approx. 50 million SEK to HANZA before transaction The rights issue is fully guaranteed though subscription undertakings and underwriting guarantees by current shareholders and external investors. The right to subscribe for new shares shall belong to those persons who on the record date for the new issue of shares are recorded as shareholders of the company, where 1 existing share shall entitle to 1 new share in the rights issue. In the event that all new shares are not subscribed for with pre-emption rights the board of directors shall, within the limit of the maximum number of shares to be issued, resolve on allocation of shares that are not subscribed for with pre-emption rights. Such allocation shall firstly be made to the guarantors who have stated in their underwriting guarantees that they wish to have a prioritised amount in the allocation of the shares not subscribed for with pre-emption rights whereby the distribution among them shall be in accordance with the respective prioritised amount of each guarantor, or if full allocation cannot be made, pro rata in relation to each guarantor’s prioritised amount; secondarily to other subscribers in relation to subscribed amount, and if this is not possible, through drawing of lots; and thirdly to the guarantors who have entered into underwriting guarantees wityh regards to the rights issue (including the guarantors with a prioritised amount in the allocation in accordance with the above) pro rata in relation to the guaranteed amount (after deduction of the recieved part of the prioritised amount, if applicable). The board of directors intends to convene an extraordinary general meeting of shareholders within shortly where the board of directors intends to propose that the general meeting approves of the board of directors’ resolution on the rights issue.  The board of directors’ resolution on the rights issue, in which the record date for obtaining subscription rights and the other terms of the rights issue is stated, will be included in its entirety in the notice to attend the general meeting. The Company will prepare a prospectus in connection with the rights issue. The prospectus is expected to be made public in August 2015. About the directed issue of new shares for the fulfilment of the share part of the purchase price The board also intends to propose that extraordinary general meeting resolves to authorise the board of directors to resolve on a directed issue to the current shareholders of Metalliset consisting of no more than 3 026 369 new shares in the Company at a subscription price of SEK 5.8 per share, as the share part of the agreed purchase price. Payment for the new shares shall be made by way of set-off against the claim for payment of a part of the purchase price for the shares of Metalliset in accordance with the share purchase agreement entered into between the Company and the current shareholders of Metalliset. Miscellaneous The rights issue and the authorisation described above require a decision in accordance with the board of directors’ proposal at the general meeting.  The board of directors intends to convene an extraordinary general meeting within shortly to discuss the questions above. Further, the board of directors also intends to propose an amendment of the articles of association in order to change the limits on the number of shares and the share capital and to propose the general meeting authorises the board of directors to resolve on share issues in certain other cases. The election committee has also announced that it, as a consequence of the acquisition of Metalliset, intends to propose changes to the composition of the board of directors as well as changed principles for the composition of the election committee. Advisors Advokatfirman Lindahl, Uppsala, is HANZA’s legal advisor and Beringer Finance is HANZA’s financial advisor in connection with the acquisition and the rights issue. 

Disclosure notification under chapter 2, section 9 of the Securities Market Act

Nurminen Logistics Plc                Stock Exchange Release 1 July 2015 at 2 p.m.     Nurminen Logistics Plc has received the following disclosure notifications of changes in portions of holdings on 1 July 2015, pursuant to the Securities Markets Act. JN Uljas Oy has announced to Nurminen Logistics Plc that as a part of the 4th June 2015 announced directed share issue, JN Uljas Oy subscribed 1,250,000 new shares which are now registered in the Trade Register. Due to the above mentioned transaction JN Uljas Oy's portion of Nurminen Logistics Plc's total number of shares and voting rights has increased over 20 per cent (1/5). JN Uljas Oy's share capital now comprises 3,099,388 Nurminen Logistics Plc's shares which are equivalent to 21.4% of Nurminen Logistics Plc's share capital and voting rights. Before the transaction JN Uljas Oy's share capital comprised 1,849,388 shares (14.2% shares and votes). JN Uljas Oy (business ID 0717307-8) is a company controlled by member of Nurminen Logistics Plc’s Board of Directors Juha Nurminen. In addition Juha Nurminen controls directly or indirectly Nurminen Logistics Plc's shares and votes as follows: Juha Nurminen owns directly 5,575,546 shares (38.5% of the share capital and votes). Nurminen Logistics PlcOlli PohjanvirtaPresident and CEO For more information, please contact: Olli Pohjanvirta, President and CEOTel. +358 10 545 2431 DISTRIBUTION                                                                     NASDAQ OMX HelsinkiMajor Mediawww.nurminenlogistics.com Nurminen Logistics is a listed company established in 1886 that offers logistics services. The company provides high-quality railway transports, project transport services, special transports and forwarding and cargo handling services to its customers. The main market areas of Nurminen Logistics are Finland, Russia and its neighbouring countries.

Goathland Station celebrates 150th anniversary

Goathland Station today celebrates a significant anniversary , 150 years to the day since the ‘deviation route’ that led to its construction was opened on the North Yorkshire Moors Railway. The deviation route was constructed during the early 1860s as a workaround for the Beckhole Incline – a steep slope which engines were pulled up by a stationary steam engine at the top – enabling trains to run the length of the line from Pickering to Whitby without any additional assistance.  As part of the deviation, Goathland station was built on the site of the former Goathland Mill. “Steep hills always cause challenges for railways, as the wheels are not able to gain sufficient traction to pull a fully loaded train up the hill, and in the moors, this was a particular challenge.  Although the rope-pull mechanism at Beckhole Incline functioned adequately, it did interrupt the journey, which is why the railway was diverted around the smoother inclines around Goathland,” explains Philip Benham, managing director of the railway.  “When the new diversion opened on 1 July 1865, it meant that trains could run uninterrupted between Pickering and Whitby for the first time, although the railway’s owners at the time kept the Beckhole route intact for a further three years and, indeed, the branch continued to operate for many more years.” Documents in the North Yorkshire Moors Railway archive show that the tender for completing the deviation was won by Thomas Nelson for a price of £56,000.  Its implementation required the construction of four stone overbridges, seven stone underbridges and one stone viaduct. Visitors today can still walk the old ‘Rail Trail’, with a recommended starting point at Goathland, where passengers can disembark the train and walk to Grosmont to pick up the next service.  “This is a great walking trail for families, at around three and a half miles long, and mostly downhill through the beautiful North York Moors national park,” adds Philip. The line of the deviation is still fully functional today, with services running daily throughout the summer.  For more details or a timetable, please visit www.nymr.co.uk ENDS A selection of pictures of today's Victorian visitors to the railway (Don and Kathryn Holton) are available by following the links at the bottom of this email, or by visiting http://news.cision.com/north-yorkshire-moors-railway For further media information or photographs, please contact: Jay Commins Pyper York Limited Tel:         01904 500698 Email:    jay@pyperyork.co.uk

Sweco now controls approximately 62% of all outstanding Grontmij shares committed to the intended recommended public offer.

On 1 June 2015, Sweco AB (publ) (“Sweco”) and Grontmij N.V. (“Grontmij”) jointly announced the intended recommended public offer by Sweco for all issued and outstanding ordinary shares in the capital of Grontmij for an offer price of EUR 1.84 in cash (cum dividend) and 0.22195 Sweco B share for each Grontmij ordinary share, subject to customary conditions (the "Offer"). On 26 June 2015, Sweco and Grontmij confirmed that they are making good progress on the preparations of the offer. As communicated before, based on the required steps and subject to the necessary approvals, settlement of the Offer is expected to take place in the second half of 2015. Sweco today announces that it has acquired 6,231,865 ordinary shares in Grontmij from Delta Lloyd Levensverzekering N.V. and Delta Lloyd Deelnemingen Fonds N.V. Including Grontmij shares that Sweco has previously purchased, Sweco now owns 6,789,492 ordinary shares in Grontmij, in total representing 8.98% of the total outstanding shares of the company. In combination with irrevocably committed shares, Sweco now controls approximately 62% of all shares in Grontmij committed to Sweco’s intended public offer. Pursuant to the provisions of Section 5 paragraph 4 and paragraph 5 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) Sweco announces that on 1 July 2015 Sweco and its affiliates or brokers (acting as agents for Sweco or its affiliates, as applicable) conducted transactions in ordinary shares of Grontmij, the details of which are stated below. Date Transaction Total Type of Volume weighted average price (€) type number shares shares1 July Purchase 6,231,865 Ordinary 4.33  2015 The highest price per ordinary Grontmij share paid in any transaction, whether or not on a regulated market as defined in Section 1 paragraph 1 of the Dutch Financial Supervision Act (Wet op het financieel toezicht), conducted on 1 July 2015 was € 4.38 per ordinary Grontmij share[1] (http://connect.ne.cision.com#_ftn1).Following such transactions, Sweco currently holds a total of 6,789,492 ordinary shares in Grontmij, representing 8.98% of the issued share capital of Grontmij[2] (http://connect.ne.cision.com#_ftn2). Grontmij does not hold any shares in the capital of Sweco. In accordance with Part 5.3.3 of the the Dutch Act on the Financial Supervision (Wet op het financieel toezicht), Sweco has notified the Netherlands Authority for the Financial Markets (Stichting Autoriteit Financiële Markten) that it has acquired a substantial holding of 8.98% in the shares in Grontmij. Sweco might purchase additional ordinary shares in Grontmij. Sweco will announce such additional acquisitions on its website (www.swecogroup.com) promptly and in any event once each day such additional acquisition has been made, or acquisitions have been made. To the extent permissible under applicable regulations, such announcements will be made in the English language only. General restrictions The information in this press release is not intended to be complete. This announcement is for information purposes only and does not constitute an offer or an invitation to acquire or dispose of any securities or investment advice or an inducement to enter into investment activity. This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire the securities of Grontmij in any jurisdiction. ---------------------------------------------------------------------- [1] (http://connect.ne.cision.com#_ftnref1) This price paid was lower than the implied value of the offer price in the Offer at the time it entered into such transaction(s) outside Euronext Amsterdam determined by multiplying the Sweco share price at the time of the transaction(s) by the exchange ratio and adding the cash part of the offer price. [2] (http://connect.ne.cision.com#_ftnref2) Comprising ordinary shares and cumulative convertible preference shares.

Electrolux contests the U.S. Department of Justice’s opposition to the acquisition of GE Appliances

On September 8, 2014, Electrolux announced it had entered into an agreement to acquire GE Appliances, a well-known manufacturer of kitchen and laundry products in the United States, for a cash consideration of USD 3.3 billion. Electrolux does not agree with the DOJ’s assessment that the acquisition will harm competition. Electrolux believes the acquisition will increase competition and provide consumers access to a greater choice of high quality products at a wider range of competitive prices. The acquisition is intended to enhance Electrolux scale and efficiencies in order to invest more in innovation and growth for the benefit of all consumers, retailers, employees and shareholders. Electrolux also finds DOJ’s opposition to be wholly inconsistent with its 2006 decision to approve Whirlpool’s acquisition of Maytag – at the time one of Whirlpool’s major competitors on the U.S. home appliance market. “The appliances industry is more competitive than ever,” said Keith McLoughlin, President and CEO of Electrolux.  “We believe this acquisition accelerates consumer innovation, which improves the industry as a whole, and results in more consumer choice than ever.” Electrolux has already obtained regulatory approval in Brazil, Canada and Ecuador. The transaction is subject to filing requirements in a few more countries in Latin America. Electrolux remains confident in its assessment of the competitive merits of this transaction and its favorable impact on consumers and Electrolux therefore still expects the transaction to close in 2015. The transaction is expected to generate annual cost synergies of approximately USD 350 million. The largest are expected to come from sourcing, operations and logistics. Telephone conferences today and tomorrowToday, Wednesday July 1, Electrolux will host a media telephone conference for its legal advisors to discuss its defense and legal options for the planned acquisition. The conference call will begin at 2215 CET (1615 ET). Details for the call are as follows:Participants in the U.S. should call +1 (844) 327-4622Other participants should call +1 (682) 888-5022Conference ID#77924983 On Thursday, July 2, an investor telephone conference will be held with Keith McLoughlin, President and CEO of Electrolux, and Tomas Eliasson, CFO. This conference call will begin at 0830 CET (0230 ET). Details for the call are as follows:Participants in Sweden should call +46 (8) 505 564 74Participants in the UK/Europe should call +44 (203) 364 5374Participants in the U.S. should call +1 (855) 753 2230

Dubious impact of interest rate cuts on corporate investments

· Of the Swedish companies, 5 percent actually believe that investment has decreased as an effect of the low interest rates. · Of the Swedish companies surveyed, 11 percent believe that investment has increased. “We need to generate predictability by means of broad political solutions that entrepreneurs and investors believe will apply for an extended period of time. To get the wheels turning faster and jobs being created at a higher rate, there are other factors than interest rates to focus on. A positive view of the future requires stability and predictability. A record-low rate does not signal stability, but rather that we are in an extraordinary situation,” says Lars Wollung, CEO of Intrum Justitia. How have investments been affected by the low interest rates?/European Payment Report 2015 Quick payment means jobs · From the European Payment Report 2015, it can also be discerned that slightly less than one in four companies (23 percent) say that there is a correlation between late payment and their being unable to recruit additional personnel. · Of the Swedish companies, 13 percent say they would be able to recruit if they received payment more quickly. That corresponds to 85,000 Swedish companies that would be able to recruit new personnel. · Seven out of ten companies (69 percent) say that the reason for late payment is a deliberate strategy on the part of the customer. Just as many (69 percent), say that late payments are caused by administrative shortcomings. · In the survey, every second Swedish firm (50 percent) feel that longer credit periods are demanded of them than they are comfortable with. “Our survey confirms that there is a clear link between healthy, predictable cash flows and companies’ ability to grow and develop. It is clear that stable and predictable cash flows result in companies being able to recruit. Consequently, strong factors motivating buyers to pay their debts ought to be high on the politicians’ agenda,” says Lars Wollung, CEO of Intrum Justitia. Intrum Justitia at Almedalen During the Almedalen Week, in which Swedish politicians and opinion makers meet and debate on the island of Gotland, Intrum Justitia will present the results of the European Payment Report 2015 at a seminar at the Donnersska House on Thursday, 2 July at 12:00 noon. The seminar will include the following participants: Anna Felländer, Chief Economist, Swedbank. Dan Olofsson, entrepreneur. Peter Strannegård, Head of Operations, Customer Services, Fortum. Jessika Roswall, Member of the Riksdag (Swedish parliament) for the Moderate Party, Lars Wollung, President and CEO, Intrum Justitia.Link to the seminar in Almedalen programme:http://www.almedalsveckan.info/event/user-view/32441?redir=%23eidx_0 About The European Payment Report 2015 The European Payment Report is Europe’s largest survey about late and defaulted payments. The report is based on a survey conducted simultaneously in 29 European countries in March-April 2015. In the report, we compile data from thousands of companies in Europe to gain insights regarding payment behaviors and the financial climate among European companies. The European Payment Report is compiled by Intrum Justitia. For further information, please contact: Annika Billberg, IR & Communications Director, Intrum Justitia, +46 (0)702-67 97 91a.billberg@se.intrum.com

Apotek Hjärtat to divest its care and nursing business to ApoEx

Vård och omsorg is a business area of Apotek Hjärtat that provides pharmaceuticals and related services to the healthcare sector in several regions and county councils as well as to a number of private healthcare providers. The business area currently has agreements with eight of the 21 county councils/regions in Sweden. The business area also includes Apovet, with a strong position in the Swedish market for veterinary medicines. The buyer, ApoEx, is Sweden’s largest privately owned supplier of pharmaceuticals to the healthcare sector and is active in the same areas. “As part of ICA Gruppen, it is logical for Apotek Hjärtat to refine its pharmacy business towards the outpatient care market. By the same token, I am convinced that ApoEx will be a focused owner that continues to develop the business in the right direction,” comments Anders Nyberg, CEO of Apotek Hjärtat. Apotek Hjärtat’s Vård och omsorg business area had sales of approximately SEK 830 million in 2014. The divestment is expected to have only a marginal effect on Apotek Hjärtat’s operating profit. The deal is contingent upon approvals from the Competition Authority and the Medical Products Agency, and is expected to be completed during the fourth quarter of 2015.     For more informationICA Gruppen press service, telephone number: +46 10 422 52 52 ICA Gruppen AB discloses the information provided herein pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 07.45 CET on Thursday, 2nd July 2015.    ICA Gruppen AB (publ) is a leading retail company with a focus on food and health. The Group includes ICA Sweden and Rimi Baltic, which mainly conduct  grocery retail, ICA Real Estate, which owns and manages properties, ICA Bank, which offers financial services, and Apotek Hjärtat, which conducts pharmacy operations. The Group also includes the wholly owned portfolio company inkClub and the partly owned portfolio company Hemtex. For more information see icagruppen.se (http://www.icagruppen.se/).

Clas Ohlson opens new store in Helsinki, Finland

During the 2015/16 financial year, Clas Ohlson plans to establish a total of 10-15 new stores. The total number of future store establishments under contract is 14. Clas Ohlson currently offers online shopping in all its markets and has a total of 199 stores, of which 81 are situated in Sweden, 73 in Norway, 32 in Finland, 12 in the UK and a franchise store in Dubai. Future store openings Sweden Bergvik Shopping Centre, Karlstad scheduled to open in August 2015 Center Syd, Löddeköpinge, scheduled to open in October 2015 Mall of Scandinavia, Solna, Stockholm scheduled to open in November 2015 Uddevalla Torp, Uddevalla, scheduled to open in spring 2016 Umeå Syd, Umeå, scheduled to open in spring 2016 Norway Sandefjord, scheduled to open in autumn 2015 Svolvær, scheduled to open in August 2016 Finland Iso Omena, Espoo, scheduled to open in October 2015 Mylly Shopping Centre, Raisio, scheduled to open in November 2015 Kaivotalo, Helsinki, scheduled to open in October 2016 UK St Albans, London, scheduled to open in September 2015 Germany Jungfernstieg, Hamburg, scheduled to open in summer of 2016 Altona, Hamburg, scheduled to open in autumn of 2016 Alstertal, scheduled to open in autumn of 2016 For more information, please contact: Sara Kraft Westrell, Director of Information and Investor Relations, phone +46 247 649 13 Sampo Päällysaho, Managing Director of Clas Ohlson Oy, Finland, mobile +358 438 244 431

EQT VI acquires HusCompagniet in Denmark

· EQT VI to acquire HusCompagniet, a leading Danish single family brick-house retailer · EQT VI to support HusCompagniet with both continued growth in Denmark and an international expansion EQT VI has entered into a definite agreement to acquire HC TopCo A/S (“HusCompagniet” or the “Company”) from Danish FSN Capital III. HusCompagniet is a market leader in the single family brick-house market in Denmark and has attractive market positions in Germany and Sweden. By combining a concept of trademark quality, a first class consumer brand and customer focus, HusCompagniet has raised the number of delivered houses rapidly resulting in increasing market shares. The Company operates with a unique asset-light business model, collaborating with a distinct group of sub-contracted construction professionals to deliver quality houses at industry leading delivery times. During 2014, HusCompagniet delivered a total of 1,010 houses. Revenues for 2014 amounted to DKK 1.8 billion with an EBITDA of DKK 189 million. HusCompagniet has 230 employees. With EQT VI as a new owner, the Company’s business plan will focus on continued growth through, for instance, additional market penetration across Northern Europe. “EQT has followed HusCompagniet for several years and we are impressed by the quality and dedication of both the employees and management. We are also impressed by the strong Danish market position and the fast growing positions in Germany and Sweden. We believe HusCompagniet has an excellent platform to pursue further growth,” says Morten Hummelmose, Partner at EQT Partners, Investment Advisor to EQT VI. “We are excited to have EQT VI as our new owner. As part of the EQT family, we hope to be able to leverage the international network of EQT and its expertise in supporting growth strategies. Together with EQT, we will continue to develop HusCompagniet and further develop our position as the leading Northern European single-family brick-house retail concept,” says Steffen Baungaard, CEO of HusCompagniet. Closing of the transaction is expected in August, subject to customary anti-trust approvals. The parties have agreed not to disclose the transaction value. EQT VI has been advised by PwC Corporate Finance, Plesner and PwC Transaction Services. Contacts: Morten Hummelmose, Partner at EQT Partners, Investment Advisor to EQT VI + 45 3312 1236 Kerstin Danasten, EQT press contact +46 8 506 55 334 About EQT EQT is the leading private equity group in Northern Europe, with portfolio companies in Europe, Asia and the US with total sales of more than EUR 17 billion and approximately 140,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. For further information please visit www.eqt.se About HusCompagniet HusCompagniet is a market leader in Denmark and rapidly growing positions in Germany and Sweden. HusCompagniet builds on a strong brand and business model, delivering high quality single-family houses with great value for money. By taking large market shares in recent years, the Company is now three times larger than the nearest competitor on the Danish market. In 2014, HusCompagniet delivered 1,010 houses to customers in Denmark, Sweden and Germany. The revenue has grown from DKK 1.2 billion in 2011 to DKK 1.8 billion in 2014. The company employs 230 people. HusCompagniet have been awarded House Builder of the Year in Denmark the last three years. For further information please visit www.huscompagniet.dk

Magnus Ahlqvist appointed Divisional President, Security Services Europe

Magnus comes from Motorola Mobility, a Google company before it was recently taken over by Lenovo. Magnus has during the past years been Corporate Vice President of EMEA and India in Motorola. Before, he worked 12 years for Sony Ericsson Mobile Communications. His assignments were, among others, President of Sony Mobile Communications in China for three years, Vice President and General Manager Spain & Portugal and Telefonica for three years and General Manager for Sony Ericsson in Canada during three years. Magnus Ahlqvist, 41 years old, holds a Master of Science in Economics and Business Administration from Stockholm School of Economics, and leadership exam from Harvard Business School. He will be located at Securitas United Kingdoms’ office in central London. This press release is also available at: www.securitas.com Information:Gisela Lindstrand, Senior Vice President Corporate Communications and Public Affairs, Securitas AB, mobile +46 70 287 8662, or email gisela.lindstrand@securitas.com Securitas is a global knowledge leader in security. From a broad range of services of specialized guarding, technology solutions and consulting and investigations, we customize offerings that are suited to the individual customer’s needs, in order to deliver the most effective security solutions. Everywhere from small stores to airports, our 320,000 employees are making a difference. Securitas AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 8.00. (CET) on July 2, 2015.

Cortendo Provides 2015 Half-Year Update on Corporate Progress

Cortendo Expands Board of Directors and Management TeamCortendo Provides Update on COR-003 Phase 3 Clinical Development ProgramCortendo Builds Rare Endocrine Disease Franchise with Completion of Transactions for Two-Late Stage AssetsCortendo Closes Aggregate $59.6 Million in Two Private Placement Financings and Provides Update on Cash Position July 2, 2015 – Göteborg, Sweden and Trevose, Pa., USA – Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare diseases, today announced an update on 2015 half-year corporate progress.“The significant leadership experience and industry expertise of our Board of Directors and Management Team are tremendous assets as we continue to build a leading biopharmaceutical company focused on addressing unmet needs in rare diseases, including rare endocrine disorders such as Cushing’s Syndrome and acromegaly,” said Matthew Pauls, president and chief executive officer of Cortendo. “We look forward to simultaneously advancing development and pre-commercialization activities for COR-003, COR-004 and COR-005, as we continue to explore additional late-stage and commercialized opportunities in endocrinology and other therapeutic areas,” Pauls added. Cortendo Expands Board of Directors and Management TeamCortendo has expanded its Board of Directors and Management Team to help execute against its strategic plans be a leader in commercializing innovative medicines for rare endocrine disorders and other rare diseases. Earlier this year, the Company welcomed two new members to its Board of Directors with the appointments of John H. Johnson as Chairman and Richard Kollender as Director. In addition, Cortendo’s Management Team has grown this year with the additions of A. Brian Davis as Chief Financial Officer and Stephen Long as Chief Legal Officer.   Cortendo Provides Update on COR-003 Phase 3 Clinical Development ProgramCortendo’s lead product candidate, COR-003 (levoketoconazole), is currently being studied in a pivotal Phase 3 clinical trial for the treatment of endogenous Cushing’s Syndrome. The Phase 3 trial continues to progress on trial implementation and recruitment. We expect to report top-line data during the first half of 2017 and, subject to a completed trial with supporting data, to file applications for regulatory approval in the United States and the European Union in the second half of 2017. For more information about the trial, visit http://www.cushingssyndromestudy.com/. Cortendo Expands Rare Endocrine Disease Franchise with Completion of Transactions for Two-Late Stage AssetsCortendo has completed its previously announced transactions to in-license commercialization rights to Antisense Therapeutics’ ATL1103 for endocrinology applications and to acquire Aspireo Pharmaceuticals’ Somatoprim (DG3173), an investigational compound being studied for the treatment of acromegaly. ATL1103, now known as Cortendo’s COR-004, is a novel second-generation antisense compound designed to block the synthesis of growth hormone receptor (GHr) thereby reducing levels of insulin-like growth factor-1 (IGF-1) in the blood. It is in clinical development for the treatment for acromegaly.  Under the terms of the license agreement, Cortendo provided Antisense Therapeutics with an initial upfront payment of $5 million, consisting of $3 million in cash and a $2 million investment in Antisense Therapeutics equity. DG3173, now known as Cortendo’s COR-005, is a next-generation somatostatin analog (SSA) with a unique receptor affinity profile, being investigated for the treatment of acromegaly, with potential additional applications in Cushing’s Syndrome and neuroendocrine tumors. Under the terms of the agreement, Cortendo provided Aspireo Pharmaceuticals approximately $30 million in Cortendo equity, calculated using a subscription price of $1.3222 per share. In addition, as part of Cortendo’s related round of financing, TVM Capital, Aspireo Pharmaceuticals’ primary shareholder, purchased $4.25 million of Cortendo shares in the private placement described below. The issuance of shares for use in the acquisition of COR-005 was approved by Cortendo shareholders at an Annual General Meeting (AGM) on June 25, 2015. Cortendo Closes Aggregate $59.6 Million in Two Private Placement Financings and Provides Update on Cash PositionCortendo also announced today that the Company has closed its previously announced second private placement financing of the year totaling approximately $33.2 million with leading U.S. and EU institutional investors, including Longwood Capital, TVM Capital and Granite Point Capital. Several existing investors, including RA Capital Management, New Enterprise Associates, Broadfin Capital and HealthCap, have also extended their investments in Cortendo through this round of financing.  In addition, Management and key advisors invested $0.5 million in the private placement. The subscription price was $1.3222 per share and 25,128,559 new shares were issued to the investors. The issuance of these additional shares was approved by Cortendo shareholders at an AGM on June 25, 2015. As announced on February 11, 2015, Cortendo previously closed a private placement totaling approximately $26.4 million.  That round of financing included leading U.S. institutional specialist healthcare investors RA Capital Management, New Enterprise Associates and Broadfin Capital. HealthCap also participated, increasing its existing investment in Cortendo.  The investments in 2015 built off an $11 million investment in late 2014, bringing Cortendo’s total raises from private placements to more than $70 million in approximately seven months. “We want to thank all of our investors for their confidence in Cortendo, its leadership team and mission to become a leader in commercializing innovative medicines for rare endocrine disorders and other rare diseases,” said Matthew Pauls, president and chief executive officer of Cortendo. "This latest round of financing strengthens Cortendo’s ability to further develop and prepare to commercialize the Company’s rare endocrine disease franchise,” Pauls added.  As of June 30, 2015, Cortendo had cash and cash equivalents of $54.4 million, which includes the cash impact of the private placement as well as the Aspireo and Antisense transactions.  Following the issuances of common stock for the private placement and the Aspireo transaction, the Company has approximately 207 million shares outstanding. About Cortendo ABCortendo AB is a biopharmaceutical company incorporated in Sweden and based in the United States. Cortendo's strategic focus is to be a leader in commercializing innovative medicines for rare endocrine disorders and other rare diseases. Cortendo’s lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is currently being studied in the global Phase 3 trial for the treatment of endogenous Cushing’s syndrome. COR-003 (levoketoconazole) has received orphan designation from both the European Medicines Agency and the U.S. Food and Drug Administration. Cortendo's intent is to independently commercialize its orphan/endocrine assets in key global markets. About COR-004COR-004 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-1 (IGF-1) in the blood and is a potential treatment for diseases associated with excessive growth hormone and IGF-1 action, such as acromegaly. Acromegaly patients have significantly higher blood IGF-1 levels than healthy individuals. Reduction of these levels to normal is the treatment goal and accepted by regulatory authorities as the primary marker of an effective drug treatment for the disease. GHr is a clinically validated target in the treatment of acromegaly.  In a Phase 2 trial in acromegalic patients, COR-004 met its primary efficacy endpoint by showing a statistically significant average reduction in serum IGF-1 levels from baseline (P<0.0001) at week 14 (one week past the last dose) at the twice weekly 200 mg dose tested. Antisense is currently undertaking a higher dose study (2 x 300 mg/week) in acromegaly patients. About COR-005COR-005 is a somatostatin analog (SSA) that is based on a novel amino acid composition and a differentiated backbone cyclization technology used for metabolic stabilization of the peptide.  During extensive preclinical testing, COR-005 demonstrated a novel pattern for somatostatin receptor binding and a pharmacological profile that is significantly differentiated from SSAs that are currently marketed or in clinical development. In particular, COR-005 has demonstrated in preclinical models potent inhibition of growth hormone secretion with less effect on insulin, a key hormone for metabolic control. Furthermore, more adenomas, derived from patients with acromegaly, showed suppression of growth hormone secretion when cultured and treated in vitro with COR-005 as compared to a currently approved SSA, suggesting that COR-005 has the potential to increase the response rate of acromegaly patients to SSA therapy. In three Phase 1 clinical trials and in two Phase 2, single ascending dose clinical trials in patients with acromegaly, inhibition of growth hormone secretion and reduced inhibition of insulin secretion or induction of hyperglycemia was observed confirming the preclinical differentiated profile of COR-005. Cortendo Forward-Looking StatementsThis press release contains forward-looking statements concerning Cortendo that involve a number of risks and uncertainties. All statements other than statements of historical facts included in this press release, including, without limitation, statements regarding Cortendo's strategy, anticipated investments, financial position, outcomes of product development efforts and objectives of management for future operations, may be deemed to be forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Cortendo's actual results, performance or achievements or industry results to be materially different from those contemplated, projected, forecasted, estimated or budgeted, whether expressed or implied, by these forward-looking statements. Given these risks and uncertainties, investors should not place any undue reliance on forward-looking statements as a prediction of actual results. None of these forward-looking statements constitutes a guarantee of the future occurrence of such facts and data or of actual results.  These statements are based on data, assumptions and estimates that Cortendo believes are reasonable. The forward-looking statements contained in this document are made only as of the date hereof. Cortendo expressly disclaims any obligation or undertaking to release publicly any updates of any forward-looking statements contained in this press release to reflect any change in its actual results, assumptions, expectations or any change in events, factors, conditions or circumstances on which any forward-looking statement contained in this press release is based. Contacts:Cortendo AB:Elixir Health Public RelationsLindsay Rocco+1 862-596-1304lrocco@elixirhealthpr.comSwedenBox 47SE-433 21 PartilleTel. / Fax. +46 (0) 31-263010USA900 Northbrook DriveSuite 200Trevose, PA 19053Tel. +1 610-254-9200Fax. +1 215-355-7389

Cherry acquires leading online casino targeting German-speaking markets

Almor’s principal brands Sunmaker, Sunnyplayer and Kingplayer have established a strong position in their core markets since the business launched in 2011, offering a large range of online casino games and a sportsbook. These brands had over 55,000 active customers in the first 5 months of 2015 and a registered customer database of approximately 355,000. We believe that the business is the largest operator of Merkur Slots, developed by Edict eGaming, which are amongst the most poular slots titles in Almor’s core markets. Fredrik Burvall, President and CEO of Cherry, commented: "Cherry has developed a strategic position in Germany, where we already hold all currently available online casino licenses, including in Schleswig Holstein. With this acquisition, Cherry immediately becomes a major online casino player in this major European market. In the short-term this enables Cherry to grow significantly and to strengthen the Online Gaming business division. The deal gives Cherry a larger and more significant presence in continental Europe, contributing positively to both our margins and our growth prospects." Almor was founded and continues to be managed by online gaming industry veterans with a successful track record. The management team have over 15 years’ experience in the sector, having held senior roles at Sportingbet, Full Tilt and CasinoClub. This management team will retain a significant shareholding in Almor and will continue to run the business with a focus on international expansion of its core brands, as well as supporting the running of Cherry’s existing German business. Alexander Knopf, director of Almor, added: “We are delighted to be joining Cherry, whom we believe to be the ideal partner for Almor to continue its remarkable growth. Cherry’s international reach, multiple licenses, flexible technology platform and in-house game development will be highly complementary to our local market knowledge, established brands and customer base.” The acquisition is expected to enable Cherry to increase both revenue and profit, as well as giving the company a stronger position in the German speaking market. Almor’s net gaming revenue for 2014 was € 11.1 m, with a profit of € 1.2 m. Since 1 January 2015, Almor has incurred VAT charges at 19%. However, this has been offset by a strong trading performance, generating net gaming revenue of €5.9 m and an EBITDA of € 0.8 m in the first five months of 2015. The purchase price for 71 percent of the shares in Almor Holding Limited is € 4.6 m (MSEK 42.7). Cherry has the right to buy the remaining part of Almor within the next four years and eight months. Payment of the initial purchase price will be made 50% in cash and 50% in Cherry shares. Further purchase consideration can be made in Cherry shares or in cash at Cherry’s discretion. The shares will be valued based on the average closing price in the three (3) trading days prior to and three (3) trading days including and following this announcement, in relation to the payment for the Initial Shares. Almor was advised on the transaction by Akur Capital. For further information, please contact: Fredrik Burvall, CEO Cherry AB (plc), Telephone +46 8-514 969 52, +46 709 279 632, Email: fredrik.burvall@cherry.se Cherry in brief Cherry is a Swedish gaming company established in 1963 specialized in online casinos and lotteries; (www.cherrycasino.com, www.EuroLotto.com, www.EuroSlots.com, www.SpilleAutomater.com, www.NordicSlots.com,www.NorgesSpill.com and www.SveaCasino.com (http://%20www.SveaCasino.com)), affiliate business (www.SuomiCasino.com and www.NorgeKasino.com etc.) and games development (www.Yggdrasil.com), through subsidiaries in Malta. Cherry is the market leader in casinos in restaurants and nightclubs in Sweden.Cherry employs around 750 people and has more than 2,600 shareholders. The Company's B-shares are listed on AktieTorget.

Q-FREE – SYNTHETIC OPTIONS GRANTS

CFO, Roar Østbø, has been granted 150,000 synthetic options. Østbø holds 108,000 shares in Q-Free ASA in addition to the synthetic options. VP RUC, Marianne Sandal, has been granted 100,000 synthetic options. Sandal holds 42,000 shares in Q-Free ASA in addition to the synthetic options. VP ATMS and Acting VP NA, Morten Andersson, has been granted 100,000 synthetic options. Andersson holds 7,700 shares in Q-Free ASA in addition to the synthetic options. VP MS, Frank Kjelsli, has been granted 70,000 synthetic options. Kjelsli holds 15,000 shares in Q-Free ASA in addition to the synthetic options. VP Nordic, Pål Rune Johansen, has been granted 70,000 synthetic options. Johansen holds 7,500 shares in Q-Free ASA in addition to the synthetic options. VP ELA, Pedro Bento, has been granted 70,000 synthetic options. Bento has no shares in Q-Free ASA. VP APMEA, Per Fredrik Ecker, has been granted 70,000 synthetic options. Ecker holds 23,500 shares in Q-Free ASA in addition to the synthetic options. CTO, Jos Nijhuis, has been granted 60,000 synthetic options. Nijhuis holds 525,552 shares in Q-Free ASA in addition to the synthetic options. CSO, Henrik Stoltenberg, has been granted 60,000 synthetic options. Stoltenberg holds 14,500 shares in Q-Free ASA in addition to the synthetic options. VP Human Resources, Stein-Tore Nybrodahl, has been granted 40,000 synthetic options. Nybrodahl holds 27,000 shares in Q-Free ASA in addition to the synthetic options. Executive Administration Manager, Rita Bøe Isaksen, has been granted 40,000 synthetic options. Isaksen holds 500 shares in Q-Free ASA in addition to the synthetic options. The strike-price for the synthetic options is NOK 13.07. The options are exercisable for each of the option holders with 1/3 of the holder’s total granted options, within 30 days after presentation of respectively Q4-2016, Q4-2017 and Q4-2018. For further information please contact: CEO Thomas Falck, cell +47 468 00 767 About Q-Free Q-Free is a leading global supplier of products and solutions within Road User Charging and Advanced Transportation Management Systems. The Q-Free Group has approximately 400 employees with offices in 19 countries and presence on all continents. The Q-Free head office is in Trondheim, Norway. Q-Free is listed on Oslo Stock Exchange under the ticker QFR. www.q-free.com Twitter: @Q-FreeASA

Hoist Finance acquires large diversified banking portfolio in the UK

Hoist Finance AB (publ), a leading pan-European debt restructuring partner to international banks, has acquired the debt purchase company Compello Holdings Limited from entities managed by Cabot Square Capital. The acquisition includes a diversified banking portfolio, consisting of more than one million banking claims originated by 19 different financial institutions, and an established and proven collection platform with 178 FTE:s. The portfolio has approximately £218 million 10-year Estimated Remaining Collections as at 30 June 2015. “This transaction is firmly in line with our strategy to strengthen and expand our market position in our core markets. In addition we continue to build on key economies of scale, namely from an operational as well as an analytical perspective. The acquisition also adheres very well with our target to purchase portfolio volumes during 2015 in line with or higher than the previous years.” says Jörgen Olsson, CEO of Hoist Finance. “The acquisition further increases our reach and operational capacity and underpins Hoist Finance’s market position with core UK banking clients”, Najib Nathoo, Head of Hoist Finance UK, concludes. For further information please contact:Anne Rhenman Eklund, Group Head of Communications and IR, Hoist FinancePhone: +46 (0)72 506 14 30 About Hoist FinanceHoist Finance is a leading debt restructuring partner to international banks and financial institutions, offering a broad spectrum of advanced solutions for acquisition and management of non-performing unsecured consumer loans. Hoist Finance operates through ten in-house collection centers across Europe, complemented by local external debt servicing partners. The total carrying value of Hoist Finance’s acquired loans was approximately SEK 8.9 billion as per 31 December 2014. The parent company Hoist Finance AB (publ) is listed on Nasdaq Stockholm Mid-Cap list and its subsidiary Hoist Kredit AB (publ) is a regulated “Credit Market Company” under the supervision of the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). In Sweden, the company offers internet-based savings deposit services through HoistSpar, with around 65,000 active accounts. The information above has been published pursuant to the Swedish Securities Markets Act (Sw. lagen om värdepappersmarknaden) and/or the Swedish Financial Instruments Trading Act (Sw. lagen om handel med finansiella instrument). This information was released for publication at approximately 08.30 AM (CET) on 2 July 2015.

New Casinos Enters The UK Market

Following successful start-ups in Sweden and Denmark, New Casinos Ltd (www.new-casinos.uk) enters the licensed UK market. The company is specialised in reviews of new online casinos. New Casinos will only make reviews of regulated online casinos, licensed by the national Gambling Comission (https://secure.gamblingcommission.gov.uk/gccustomweb/PublicRegister/PRSearch.aspx). The British market currently consists of 3067 licensed casinos and betting companies, compared to merely 29 licensed firms in Denmark. Markus Jalmerot, founder of New Casinos, estimate that over 100 new casino sites will be launched in United Kingdom during 2015. Next years will likely see even higher numbers of newly licensed gambling businesses.  The UK market is growing quickly and all new online casinos creates a challenge for consumers. Gambling analysts at New Casinos Ltd points out a large number of strenghts and weaknesses of the latest additions to the British market. The site also feature over 700 land-based casinos from Europe and Asia. Gamblers planning to visit a local physical casino in those regions can find them at New-Casinos.uk. Information about dress codes, casino games available, opening times and facts about the venues are also available.  Initially, there will be 9 in-depth reviews of new online casinos in the UK. Every week, 3-4 more new companies will come under scrunity, provided there are qualified newcomers available. New Casinos will also show the latest campaigns and news for British casinos. 

Noreco reaches agreement with partners in Denmark

Stavanger, 2 July 2015: Norwegian Energy Company ASA (“Noreco” or the “Company”) announces that it has reached an agreement with its joint venture partners in Denmark with respect to its forfeited licences and related abandonment liabilities. Noreco has terminated its joint venture and its participation in the Nini and Cecile oilfields (the “Licences”). According to provisions in the respective joint operating agreements, Noreco has forfeited and transferred its participating interests in the Licences to the Partners on a pro-rata basis. In addition, the settlement for claims on defaulted cash calls and capping of the abandonment liability includes a cash consideration of NOK 60 million, and an 18.2 per cent working interest in the Lulita field. The restricted cash set aside for future abandonment liabilities will remain in escrow with and on Noreco’s balance sheet. According to the agreement, Noreco will not be held liable for abandonment costs beyond the restricted cash. Final closing of the agreement is subject to approval by the Danish Energy Agency. The agreement in Denmark leaves Noreco with full ownership of the significant Siri insurance claim, a 10 per cent working interest in the producing Lulita field, and very limited financial obligations in Denmark. Contact:Tommy Sundt, CEO. Tel.: +47 992 83 900Odd Arne Slettebø, CFO. Tel.: +47 992 83 900investorrelations@noreco.com This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Repo rate cut to −0.35 per cent and purchases of government bonds extended by SEK 45 billion

Monetary policy is having an effect – inflation is rising The Riksbank's expansionary monetary policy is having an effect and inflation is rising. In May, CPIF inflation was 1.0 per cent. Prices of goods and food are increasing in line with historical averages, while the rate of price increase on services is rising from a low level. At the same time as inflation is rising, economic activity is continuing to strengthen and the situation on the labour market is gradually improving. CPIF inflation is expected to be close to 2 per cent from the end of 2015.  An uncertain world International growth is also rising. In the euro area, economic activity is strengthening, but the events in Greece over the past few days have substantially increased the uncertainty. The consequences of the situation in Greece for the euro area as a whole and for Sweden are difficult to judge.  Since the Riksbank's most recent decision in April, the krona has strengthened more than expected against several currencies. If the exchange rate were to be too strong in relation to the Riksbank's forecast, prices of imported goods would increase more slowly and demand in the Swedish economy would fall. Such a development would risk breaking the upturn in inflation that has now begun.  Measures to support the upturn in inflation In this uncertain environment, monetary policy needs to give more support to ensure that inflation continues to rise towards the target of 2 per cent. The Executive Board of the Riksbank has therefore decided to cut the repo rate by 0.10 percentage points to ‑0.35 per cent and to extend the purchases of government bonds by a further SEK 45 billion until the end of the year. The purchases decided upon in April are expected to be concluded in September, at which point the new purchases will be initiated. The repo rate is expected to be around -0.35 per cent for just over a year. The repo-rate path reflects the fact that it is possible to cut the repo rate further. The expansionary monetary policy underlines the Riksbank's aim to safeguard the role of the inflation target as nominal anchor for price-setting and wage-formation. Readiness to do more The Riksbank still has a high level of preparedness to make monetary policy even more expansionary if necessary, even between the ordinary monetary policy meetings. The repo rate can be cut further and the government bond purchases can be extended. The Riksbank is also prepared to intervene on the foreign exchange market if the upturn in inflation is threatened as the result of, for instance, a very problematic development in the markets. The purchase of other types of securities and the launch of a company lending programme via the banks may also come into question.  Risks associated with household indebtedness must be managed Monetary policy now needs to be very expansionary so that inflation rises towards the target and to reduce the risks associated with a situation in which inflation is too low. At the same time, however, the low interest rates contribute to the trends of rising house prices and increasing indebtedness in the Swedish household sector continuing. As current debt levels already entail significant risks for the Swedish economy, it is essential that the government and other authorities implement measures that will reduce them. Rapid price increases for high-risk financial assets also require increased vigilance in the period ahead. Forecast for Swedish inflation, GDP, unemployment and the repo rateAnnual percentage change, annual average +----------------------------------+----+-----------+-----------+---------+| |2014|2015 |2016 |2017 |+----------------------------------+----+-----------+-----------+---------+|CPI |-0.2|0.2 (0.3) |2.0 (2.1) |2.7 (2.7)|+----------------------------------+----+-----------+-----------+---------+|CPIF |0.5 |1.1 (1.1) |2.1 (2.3) |2.1 (2.2)|+----------------------------------+----+-----------+-----------+---------+|GDP |2.3 |2.9 (3.2) |3.6 (3.4) |2.6 (2.7)|+----------------------------------+----+-----------+-----------+---------+|Unemployment, ages 15-74, per cent|7.9 |7.7 (7.6) |7.3 (7.2) |7.0 (6.9)|+----------------------------------+----+-----------+-----------+---------+|Repo rate, per cent |0.5 |-0.3 (-0.2)|-0.3 (-0.2)|0.2 (0.3)|+----------------------------------+----+-----------+-----------+---------+ Note. The assessment in the April 2015 Monetary Policy Report is shown in brackets.Sources: Statistics Sweden and the Riksbank Forecast for the repo ratePer cent, quarterly average +---------+-------+-------------+-------------+-------------+-----------+-------+| |2015 Q2|2015 Q3 |2015 Q4 |2016 Q3 |2017 Q3 |2018 Q3|+---------+-------+-------------+-------------+-------------+-----------+-------+|Repo rate|-0.25 |-0.37 (-0.28)|-0.41 (-0.29)|-0.33 (-0.21)|0.26 (0.38)|0.81 |+---------+-------+-------------+-------------+-------------+-----------+-------+ Note. The assessment in the April 2015 Monetary Policy Report is shown in brackets.Source: The Riksbank  Deputy Governor Henry Ohlsson entered a reservation against the decision to cut the repo rate. He considered that the repo rate and the repo-rate path should be held unchanged. Mr Ohlsson thought it was sufficient to extend and prolong the purchases of government bonds in the current economic situation. The decision on the repo rate will apply with effect from 8 July. The minutes from the Executive Board’s monetary policy discussion will be published on 15 July. Further information on the Riksbank's purchases of government bonds can be found in a separate basis for the decision on the Riksbank's website, www.riksbank.se. A press conference with Governor Stefan Ingves and Marianne Nessén, Head of the Monetary Policy Department, will be held today at 11 a.m. in the Riksbank. Press cards must be shown. The press conference will be broadcast live on the Riksbank’s website where it will also be available to view afterwards.

Green data centres make Stockholm unique in the world

“This is an important step to recovering as much energy as possible from the expanding global IT sector,” says Anders Egelrud CEO at Fortum Värme. "We hope that the Open District Heating business model, which makes this possible, will attract a large number of international data centres to set up in Stockholm, but also helps to accelerate the development of Stockholm towards a totally fossil-free system." Energy recovery is an additional competitive advantage for Stockholm that offers the opportunity to take a leading position as Europe's primary hub for information and communication technology companies. “Stockholm, with its proven expertise in the IT sector, its well-developed district heating systems and its excellent business climate is ideally placed to be a global centre for the growing data centre industry,” says Karin Wanngård, financial commissioner at the City of Stockholm.  “It is really positive that heat recovery from this future sector can contribute to our vision for making Stockholm an international forerunner in sustainable cities.” Bahnhof's data centre will be Stockholm's largest when it is established in 2016-2017. When fully developed, it will be able to recover 112 GWh of heat per year to the district heating network. This is equivalent to the entire supply of district heating to a town of about 20,000 inhabitants. The agreement between Fortum Värme and Bahnhof includes a heat recovery system and a separate system for free cooling. “Having a heat recovery system and a parallel system for free cooling will allow us to build one of the world's greenest data centres while offering very competitive prices at the same time. With Green Hub, we have demonstrated that it is smart to put data centres in city locations and recover energy instead of heating up the sky,” says Bahnhof CEO Jon Karlung. The new data centre will get its electricity supplied from a new substation being built by Ellevio which is directly connected to the data centre. “We will be making a substantial new investment to facilitate Bahnhof's expansion,” says Johan Lindehag, CEO of Ellevio. The proximity to the main grid station in combination with a brand new substation will provide Bahnhof with a secure and scalable grid connection. About Open District Heating:The Open District Heating (Fjärrvärme®) business concept, uses proven technology to enable the recovery of energy from which all parties will benefit. Previously it was impossible to utilise excess heat from data centres, which ended up as waste. Fortum has carried out similar set-ups with server halls in Finland. http://www.opendistrictheating.com/ About Fortum Värme:Fortum Värme produces district heating, district cooling and electricity. The company has contributed to Stockholm being counted among the world's cleanest capital cities and that Stockholm was designated by the EU in 2010 as the world's first environmental capital – Green Capital. Between the years 2010–2015, Fortum Värme invested SEK 7 billion in combined heat and power production in the Stockholm region. District heating in Stockholm will be entirely produced from renewable and recovered energy no later than 2030. The company has 9,500 district heating and cooling customers. The fully owned gas business sells and distributes town and vehicle gas Fortum Värme is jointly owned by Fortum (90.1% of the shares and 50.1% of the votes) and the City of Stockholm (9.9% of the shares and 49.9% of the votes). In 2013 the owners reached a new shareholder agreement, and from 1 January 2016, ownership of the company will be equally shared. In conjunction with this, the owner's agreed that Fortum Värme would be self-financed as of this date. In April 2015 Fortum Värme received a BBB+ rating from Standard & Poor's with stable prospects. More information:Jon JordåsPress Officer Bahnhof ABPhone: +46 76 111 01 63E-mail: jon.jordas@bahnhof.net Marianne AhlgrenPress Officer Fortum Värme ABPhone: +46 72 715 09 39E-mail: marianne.ahlgren@partners.fortum.com        Tomas GustavssonPress secretary Karin WanngårdPhone: +46 76 122 91 99E-mail: tomas.gustavsson@stockholm.se Jonatan BjörckPress Officer Ellevio ABPhone: +46 72 561 54 16E-mail: jonatan.bjorck@ellevio.se www.fortum.sewww.bahnhof.sewww.ellevio.se

TIDAL PRESENTS TIDAL X: RIHANNA BBHMM

(New York, NY) JULY 2, 2015—Music and entertainment platform TIDAL and Rihanna surprised fans in the Los Angeles area with a once in a lifetime experience. The singer orchestrated a surprise “kidnapping” for fans. Fans were given blindfolds and boarded onto private buses for an unknown destination. Rihanna herself is joining fans for an exclusive screening of her new video “Bitch Better Have My Money,” that was directed by Rihanna and Megaforce.  The single has been number one for the past two weeks on Urban Radio charts. It was also just announced that Rihanna has surpassed more than 100 million Gold & Platinum song certifications.  She is the first and only artist to surpass RIAA’s 100 million cumulative singles award threshold.  All music fans can enjoy the new video on TIDAL.com (http://www.tidal.com/). This is the latest exclusive TIDAL X created by TIDAL to bring fans and artists closer together. Download TIDAL X Rihanna photo below. ABOUT TIDAL TIDAL is an innovative music and entertainment platform to experience and discover music from artists around the world, enjoy access to exclusive and curated content, and connect and share with artists. TIDAL is available in 44 countries with a catalog of over 30 million songs and more than 75,000 high quality videos. The service offers high-fidelity, CD sound quality, high quality video, expertly curated content and unique offline experiences for members. Follow TIDAL at http://facebook.com/tidal and http://twitter.com/tidalhifi

Tommy Eliasson Winter takes over as alpine director

There will be some changes in the Swedish Ski Association before the 2015/2016 season since alpine director Ville Bylin has decided to leave for family reasons. – I have enjoyed two fantastic seasons as alpine director and I will certainly miss all the action with the sport. My decision has grown gradually and is based on the need to spend more time at home, says Ville Bylin. – I wish to thank Ville for an excellent job. Besides the athletic successes, he has greatly improved the team’s finances, which will provide his successor with great conditions to continue the work on sport development, says Niklas Carlsson, Secretary General. Tommy Eliasson Winter was born in Boden where he began his career in alpine skiing. In 2003 he swapped the discipline and became one of the pioneers in Swedish ski cross. He retired from competition after the Vancouver Olympic Winter Games in 2010 and became the team captain/head of discipline for ski cross, delivering great results – both from sports and financial perspectives – year after year. – It has been a fantastic journey to develop ski cross from an unknown sport to a staple on TV screens in Sweden. However, I am now ready to take another step forward and very excited about the task to develop both the national team and general participation in alpine skiing. It feels wonderful to take over such a strong organisation and work toward continued success in the build-up to and at the home championships at Åre 2019, states Tommy. Tommy will assume his new role on 1st August whilst Ville Bylin will continue to assist the transition until mid-September. For more information, contact:Niklas Carlsson, Secretary GeneralEmail: niklas.carlsson@skidor.comMobile: 070-370 01 38 Tommy Eliasson WinterEmail: tommy.eliasson@skidor.comMobile: 0731-80 83 94 Ville BylinEmail: ville.bylin@skidor.comMobile: 070-372 01 45

BP Settlement: “Time for Gulf Restoration to Begin”

This morning, BP, the U.S. Justice Department, and the five Gulf states made public the terms of a $18.7 billion settlement agreement regarding the company’s role in the 2010 Deepwater Horizon oil spill. BP will pay $12.6 billion in penalties and damages under the Clean Water Act and the Oil Pollution Act. Collin O’Mara (https://www.nwf.org/News-and-Magazines/Media-Center/Faces-of-NWF/Collin-OMara.aspx), president and CEO of the National Wildlife Federation made the following statement: “Today's settlement is a victory for the wildlife of the Gulf. This brings to a close the long legal ordeal that had left restoration efforts in limbo and it gives us certainty moving forward. Now it is time for Gulf restoration to begin in earnest. “The RESTORE Council and the Gulf States must begin the urgent task of returning these waters to a state of health and prosperity, because while the legal wrangling may be over, the disaster continues to impact wildlife. Five years later, dolphins are still dying, sea turtles are failing to nest and millions of gallons of oil remain on the floor of the Gulf. “While the company could have faced penalties as high as $13.7 billion under the Clean Water Act alone, the $5.5 billion settlement will allow significant ecological restoration to occur in the Gulf. The communities and wildlife of the Gulf have suffered greatly in the wake of the largest oil spill in U.S. history—and now, with this settlement in hand, it is essential the Gulf states and federal government ensure that every dollar in penalties and damages be used to restore this incomparable ecological treasure and economic powerhouse.” *** For information on the ongoing impacts of the disaster on wildlife, please read our recent report Five Years and Counting: Gulf Wildlife in the Aftermath of the Deepwater Horizon Disaster (http://www.nwf.org/fiveyearslater).

August is National Children’s Vision & Learning Month: Optometrists focus on Visual Symptoms from Concussions that Block Learning

August is the 20th annual observation of National Children’s Vision & Learning Month (http://www.covd.org/?page=August_VL) and a perfect time to shed light on the vision problems associated with concussions that impact academic performance. Shelby Hedges’ concussion occurred during the first soccer game of the high school season. Prior to her concussion Shelby was an avid reader, but afterwards, she had trouble with reading (http://www.covd.org/?page=Reading_Writing) and focusing as soon as she started trying to do her schoolwork. After about 1 month it was obvious her difficulties were not improving. A trip to her concussion specialist resulted in a referral to a developmental optometrist (http://locate.covd.org/) who helped Shelby return to her normal life as it was before the concussion.  According to Dr. Kara Heying, President of the College of Optometrists in Vision Development (COVD) (http://www.covd.org), “Shelby was very fortunate to have a concussion specialist who knew where to send her. Our member Doctors often see patients after they have struggled for years with no improvement.”  Kelsey Ransom wasn’t as fortunate as Shelby. Reading was already a struggle for Kelsey and after she received her second concussion playing basketball the change in her academic performance was not as obvious as when she received her first concussion. She had been diagnosed with a Non-Verbal Learning Disorder prior to this concussion and the psychologist had told her mother that her I.Q. was “off the charts,” so her mother thought that Kelsey was just “lacking focus” and she was just experiencing normal “kid” issues when her struggles got worse.  It wasn’t until Kelsey was seen by a developmental optometrist, “that it dawned on us she had residual effects from the concussion” her mother, Lori Harris-Ransom, shared; “when Kelsey was having trouble doing homework, I would tell her, ‘Kelsey you have to focus and concentrate and put in more effort.’ – I didn’t realize she wasn’t capable of doing so.” Kelsey was in 6th grade, reading at a 4th grade level. Lori explains, “She had been complaining for a year of visual issues, we just didn’t know they were due to VISION. We thought it was a learning issue.” In addition, Kelsey shared that one of her teachers would actually chastise her for not paying attention because she was writing and not paying attention to what he was saying; when in fact, she was still trying to copy information from the board before he would erase it. Once she understood her difficulties were due to a vision problem (http://www.covd.org/?page=Learning), she was able to explain the situation to her teacher.  While Kelsey is only halfway through a program of optometric vision therapy (https://covd.site-ym.com/?Vision_Therapy), she is already seeing major improvement. Lori shares, “I am seeing dramatic differences in the last couple of months. She avoided studying and felt so defeated before. She has so much more confidence now.” Before starting vision therapy Kelsey was trying to read To Kill a Mockingbird for school.  As she was improving during her vision therapy Kelsey found it easier to understand the book.  Kelsey proudly shares, “I did not have to focus on what to read and I was fully enjoying it. I read it and understood what I was reading.” Both Kelsey and Shelby had convergence insufficiency (http://www.covd.org/?page=Convergence) which is an eye teaming problem (also known as an eye coordination disorder) where the eyes don’t work together in unison; often resulting in difficulty with reading. “Convergence insufficiency is very common after a concussion,” Dr. Heying explains; “It is also very common in children who struggle with reading who have not had a concussion.” The majority of vision screenings (http://www.covd.org/?page=Exam) performed in schools and pediatricians’ offices are not designed to test for eye coordination, eye tracking, or eye focusing problems. In fact vision screenings miss at least 50% of vision problems. In addition, general eye exams often do not thoroughly evaluate all the visual skills required for academic success (http://www.covd.org/?page=visual_skills). The diagnosis and treatment of convergence insufficiency is a specialty field (http://www.covd.org/?page=Vision_Therapy) within optometry performed by developmental optometrists. A cross-sectional study was performed of adolescents (ages 11 to 17 years) from the Concussion Care for Kids: Minds Matter program at Children’s Hospital of Philadelphia with co-investigators from the Pennsylvania College of Optometry at Salus University, Michael Gallaway, OD, FCOVD, FAAO and Mitchell M. Scheiman, OD, FCOVD. Sixty-nine percent of one hundred children examined were found to have one or more vision problems.  In an interview in Infectious Diseases in Children (http://www.healio.com/pediatrics/adolescent-medicine/news/online/%7B9236c032-a1e9-4d89-88ab-cbfa33002444%7D/vision-problems-caused-by-concussion-often-overlooked), a Healio publication, pediatric sports medicine specialist and associate professor of clinical pediatrics, Perelman School of Medicine at the University of Pennsylvania, Christina L. Master, MD, FAAP, CAQSM, discussed the study; “All these children can see 20/20, but the problem is that their eyes don’t work well together. It’s the idea of eye teaming, focusing and tracking. If you go to a regular eye doctor for a vision assessment of visual acuity, the typical tests will not detect these problems that we found associated with concussion.”   In a recent study published in the June 2015 issue of the journal of the American Academy of Pediatrics, Academic Effects of Concussion in Children and Adolescents, it was found that those with higher severities of concussion experienced extended recovery time from symptoms that can interfere with academic performance. These post-concussion symptoms include problems with concentration, eyestrain, loss of place while reading, slower processing speed, headaches and fatigue. These symptoms are very similar to symptoms relating to binocular vision disorders.  “We have known for years that concussions cause vision problems (https://covd.site-ym.com/?page=BrainInjury), and these are some of the types of vision problems that developmental optometrists specialize in treating to help children get back on track with their academics after a concussion,” Dr. Heying explains; “To help parents and medical professionals in managing post-concussion children with their visual symptoms we are issuing Return to Learn: A Guide to Visual Recovery after Concussion (https://covd.site-ym.com/resource/resmgr/Images/Return_to_Learn_final.jpg).”   

News: Business update from CEO Anders Spetz.

I would like to take the opportunity to give shareholders and other stakeholders in Nexam Chemical a brief business update before the upcoming holiday period. Strategic focus Since I took over as CEO, the management and the board of directors has, as previously communicated, changed the strategic focus of the business. In order to develop Nexam Chemical to a commercial success, the way forward is spelled FOCUS. During the spring we have carefully evaluated our business opportunities, prioritized the best and matched them with our assets and resources. What we communicated during the spring is still valid – our focus today lies within pipes made from polyethylene (PE), foam made from polyester (PET) and our high performance products. Business update We can confirm that our products attract much interest from the market within our chosen areas of focus and that there are ongoing full-scale tests and some initial sales in prioritized segments. Before drawing to many conclusions from this, it should be kept in mind that it takes time for our customers to evaluate and adapt their commercial offers to generate volume sales of end products containing Nexam Chemicals technology. In several of the customer projects in progress, we can also conclude that our specialist expertise is an important part of the business case. A key component, that is critical for future development, is our ability to provide cost effective solutions. During spring and early summer we have introduced several formulations at an attractive price level in relation to created customer value. This opens up new opportunities in the high-volume segments. Meanwhile, there are some customer projects that need to step back to the laboratory in order to find the solutions. One such area relates to polypropylene (PP), which we prioritize with the ambition to develop a commercially viable solution. From research to development I am satisfied to see that we in short time have been able to shift our focus from research at a molecular level to development of applications, where our products are included as a value creating component for the customer. In our application laboratory in Lund we have intensified our tests where we simulate our customers’ production processes with NEXAMITE®-modified plastics. This way we can facilitate for our customers to adapt their production processes in order to maximize the value of Nexam Chemicals technology. Furthermore, we have completed a major restructuring of our R&D. We have consolidated all research activities to our facility in Scotland and closed our chemistry laboratory in Lund. This gives us a better use of our resources and a clearer focus where Scotland manage all research activities and QC, while Lund focus on all development of applications. Our research activities are now focused on refining the formulations for polyethylene and polyester. All ongoing new research is mainly focused on finding an effective formulation for PP (polypropylene). Cost saving program Our program for reducing cost is proceeding according to plan and we can already see positive effects of this. The operational expenses have been reduced, including the closing and relocation of chemistry laboratory in Lund, reduced external costs for e.g. advisers and downsizing of personnel. In total, the personnel in the parent company and subsidiaries have been reduced with nine employees. Primarily within administration and long-term research activities. Organization Our new CMO Lars Öhrn has now assumed his position and has started his assignment within Nexam Chemical in an exemplary manner, focused and with full speed ahead on customer activities. Through his unique experience and network, he has already brought new possibilities to the company. At the same time, we intend to strengthen our team with additional sales skills and technical customer service. These recruitment processes have already begun. Finally, I wish everyone a great summer! Nexam Chemical is open all summer and our projects are progressing continuously. Now we are doing business. Going forward, we want them to increase! Anders Spetz CEO Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Lennart Holm, Chairman of the Board, +46-706 30 85 62, lennart.holm@nexamchemical.com Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com

Swedish public prosecutor files criminal charges against two former NMG board members

Nickel Mountain Group AB (publ) (“NMG”) has been informed that the Swedish public prosecutor has filed criminal charges against two former board members of NMG, Mrssr. Ulrik Jansson and Terje Engström Lien, for their actions in connection with the Ghana Gold-transaction in 2013. As reported before, NMG has filed a civil court case against Mrssr. Jansson and Lien and the two other former board members Mrssr. Hans Lindroth and Jukka Kaillio with regard to the same transaction. In that case, NMG is claiming damages in an amount of MSEK 55 plus accrued interest due to the former board members’ negligent actions. The public prosecutor’s decision is beneficial to NMG in the sense that it indicates that the prosecutor believes he can prove that Ulrik Jansson and Terje Engström Lien committed crime when they conducted a payment of MSEK 50 in January 2013 as a prepayment for the acquisition of Ghana Gold AB. That means that the prosecutor holds that he can prove not only that they acted negligently, but in fact with intent. Should Mr. Jansson and Mr. Lien be deemed to having committed crime by the court, NMG’s civil case against these two persons will in practice also be won by NMG. Should, on the other hand, the public prosecutor lose the criminal case, the criminal charges still indicate that the former NMG board members acted in the grey zone between criminal acts and gross negligence and certainly that they acted at least negligently. NMG is pleased with the fact that the public prosecutor takes this case seriously and looks forward to following the criminal court case. Timing wise the main hearing in the criminal court case may take place before NMG’s civil court case comes up to trial in the Stockholm district court. For and on behalf of the Board of Directors of Nickel Mountain Group AB Torbjörn Ranta Managing Director For information, please contact Torbjörn Ranta Mail: torbjorn.ranta@nickelmountain.se Tel: + 46 8 402 28 00 Cell Phone: +46 708 855504 Cautionary Statement: Statements and assumptions made in this document with respect to Nickel Mountain Group AB’s (“NMG”) current plans, estimates, strategies and beliefs, and other statements that are not historical facts, are forward-looking statements about the future performance of NMG. Forward-looking statements include, but are not limited to, those using words such as "may", "might", "seeks", "expects", "anticipates", "estimates", "believes", "projects", "plans", strategy", "forecast" and similar expressions. These statements reflect management's expectations and assumptions in light of currently available information. They are subject to a number of risks and uncertainties, including, but not limited to, (i) changes in the economic, regulatory and political environments in the countries where NMG operates; (ii) changes relating to the geological information available in respect of the various projects undertaken; (iii) NMG’s continued ability to secure enough financing to carry on its operations as a going concern; (iv) the success of its potential joint ventures and alliances, if any; (v) metal prices, particularly as regards nickel. In the light of the many risks and uncertainties surrounding any mineral project at an early stage of its development, the actual results could differ materially from those presented and forecast in this document. NMG assumes no unconditional obligation to immediately update any such statements and/or forecasts.

Alfa Laval expands aftermarket business, acquires niche company with sales of SEK 50 million

The acquisition is in line with the strategy of the Alfa Laval Group of acquiring companies that complement the existing business in terms of products, geography or in the form of new sales channels. In this case the Alfa Laval Group adds a complementary aftermarket channel. “With the acquisitions we are adding presence in an important niche of the aftermarket,” says Lars Renström, President and CEO of the Alfa Laval Group. “ Did you know that… the value of the aftermarket for separation is estimated to be four times the value of new sales? About Alfa Laval                                                                                                         Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval’s products are also used in power plants, aboard ships, oil and gas exploration, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on Nasdaq OMX, and, in 2014, posted annual sales of about SEK 35.1 billion (approx. 3.85 billion Euros). The company has about 18 000 employees. www.alfalaval.com  For more information please contact:  Peter TorstenssonSenior Vice President, CommunicationsAlfa LavalTel: + 46 46 36 72 31Mobile: +46 709 33 72 31Gabriella GrotteInvestor Relations ManagerAlfa LavalTel: +46 46 36 74 82Mobile: +46 709 78 74 82

Hemfosa Fastigheter acquires school property in Karlstad with 20-year lease

Hemfosa has reached an agreement concerning the acquisition of the Blyet 2 property in Karlstad for a purchase consideration of MSEK 73.5. Gruvlyckeskolan comprises approximately 6,800 square meters of teaching premises and is currently fully leased to the Internationella Engelska Skolan i Sverige AB, which has signed a 20-year lease. The property houses an elementary school for grades four to nine. Transfer took place on July 1, 2015. “The acquisition of the Internationella Engelska Skolan’s premises in Karlstad is in line with Hemfosa’s strategy of growing in the community service properties’ segment. We look forward to further developing the property together with the tenant,” says Jens Engwall, President of Hemfosa Properties AB. For further information, please contact:Stina Lindh Hök, Head of transactions, Stina.lindh.hok@hemfosa.se, mobile +46 70 577 18 85Switchboard +46 (0)8-448 04 80    About Hemfosa FastigheterHemfosa is a Swedish property company with a well-balanced and geographically diversified property portfolio focusing on a high proportion of community service properties with the State and municipalities as the largest tenants. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. At March 31, 2015, Hemfosa owned commercial properties in Sweden with a total property value of approximately SEK 30 billion, including the company’s share of the property value in joint ventures. The company’s common share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.

Tieto's second-quarter results on 22 July – conference for analysts and media in Helsinki

Tieto Corporation   STOCK EXCHANGE RELEASE 3 July 2015, 10.00 am EET Tieto will publish its second-quarter results for 1 January–30 June 2015 on Wednesday 22 July 2015 at 8.00 am EET (7.00 am CET, 6.00 am UK time). Press conference for analysts and media will be held at Tieto’s premises in Helsinki, address: Aku Korhosen tie 2–6, at 11.00 am EET (10.00 am CET, 9.00 am UK time). The results will be presented in English by Kimmo Alkio, President and CEO, and Lasse Heinonen, CFO. The conference will be webcasted (http://webcast.tieto.com/quarterlyreport/?q=220715) and can be viewed live on Tieto's website (http://www.tieto.com/investors). To join the conference, attendees need Adobe Flash plugin version 10.1.0 or newer. The meeting participants can also join a telephone conference that will be held at the same time. The telephone conference details can be found below. Telephone conference numbersFinland: +358 (0)9 6937 9590Sweden: +46 (0)8 5065 3937UK: +44 (0)20 3427 1909US: +1212 444 0896Conference code: 8765732 To ensure that you are connected to the conference call, please dial in a few minutes before the start of the press and analyst conference. An on-demand video will be available after the conference. Tieto publishes financial information in English and Finnish. For further information, please contactTanja Lounevirta, Head of Investor Relations, tel. +358 50 321 7510, tanja.lounevirta (at) tieto.com  TIETO CORPORATION DISTRIBUTIONNASDAQ HelsinkiNASDAQ StockholmPrincipal Media  Tieto is the largest IT services company in the Nordics providing full lifecycle IT services. We also provide global product development services for companies in the communications and embedded technologies arena. Through industry insight, technology vision, and innovative thinking, Tieto proactively strives to inspire and engage our customers in finding new ways of accelerating their business. Building on a strong Nordic heritage, Tieto combines global capabilities with local presence. Headquartered in Helsinki, Finland, Tieto has over 13 000 experts in more than 20 countries. Turnover is approximately EUR 1.5 billion. Tieto’s shares are listed on NASDAQ in Helsinki and Stockholm. www.tieto.com

Stena RoRo charters three vessels on a long-term basis

Per Westling, MD, Stena RoRo, DanMikkola, MD, Godby Shipping andOlof Berndtsson, DMD, Stena RoRo, aftersigning ceremony during Stena Match CupSweden.Photo: Victoria EdströmMisida. Photo: Pär-Henrik Sjöström Three easy accessible RoRo decks enable fast turnaround in port and this, combined with their high service speed, satisfies the demand for punctual high-frequency service.“We are very satisfied with the agreement, which we believe is clearly in tune with the times in relation to the market situation. We note that growth in our niche is good and we are optimistic about the future”, says Per Westling, Managing Director, Stena RoRo.The fixtures are the first to be based on the Bimco ROPAXTIME charter-party, which was launched at the end of June and specifically developed for the RoRo/RoPax industry.”The contract negotiations have been very much facilitated by using the recently launched standard contract and consequently saved us a lot of time”, says Dan Mikkola, Managing Director, Godby Shipping.Misida, Misana and Miranda were built at the German shipyard J.J. Sietas KG Schiffswerft GmbH in 2007 and will complement the Stena fleet of more than 50 RoRo/RoPax vessels.Technical data:Length 165,75 m; Beam 23,40 m; Service speed 20 knots, Roro Capacity 2150 lane meters, DWT 11,407 tonsFor more information, please contact:Per Westling, Managing Director, Stena RoRo ABTel: +46 31 855154, +46704-855154E-mail: per.westling@stena.comDan Mikkola, Managing Director, Godby Shipping ABMobile: +358 50 5244123E-mail: dan.mikkola@godbyshipping.fiStena RoRo is one of the leading innovators of the roll on/roll off cargo and passenger concepts. Our products include vessels such as RoRos and RoPaxes. The company charters out a number of vessels to first-class operators all over the world and the clients are found both within and outside of the Stena Sphere. Stena RoRo are highly skilled and experienced in designing and converting vessels, combined with a unique knowledge of the market, to create tailor-made solutions for their demanding customers. This is called Stenability. www.stenaroro.comGodby Shipping is a privately owned shipping company established 1973. Our aim is to offer high class tailor made sea transportation for the forest industry and liner operators. We operate a modern and competitive fleet under Finnish flag. www.godbyshipping.fi

Invitation to presentation of Swedbank's interim report January - June 2015

Swedbank's interim report for January - June 2015 will be published on Thursday 16 July at 07:00 CET. You are invited to participate in the following events:Teleconference for analysts on 16 July at 08:30 CETMichael Wolf, Swedbank's president and CEO, Göran Bronner, CFO, and Anders Karlsson, CRO, will present the report. The teleconference will be in English and directly transmitted on www.swedbank.se/ir. A recording will also be available. To participate in the teleconference please telephone +46 8 505 564 74 or +44 203 364 5374 five minutes before the start of the teleconference.Lunch presentation for investors and analysts in Stockholm on 16 July at 11:30 CETMichael Wolf, president and CEO, and Göran Bronner, CFO, will present the report and answer questions. The presentation will be held at Swedbank, Regeringsgatan 30-32, Stockholm. Entry is via lift A, floor 4. The presentation will be in Swedish and is expected to end by 13:00 CET. Please register your attendance by email at corporateaccess@swedbank.se (http://file:///R:/Staber/Corporate%20Affairs/Media%20Relations/Pressreleaser/Engelska/2015/mail%20to:corporateaccess@swedbank.se) by Friday 10 July. Media interviewsMedia representatives are welcome to book interviews with Michael Wolf, CEO, on 16 July between 9.45 and 10.30 CET. Please contact Anna Sundblad, Group Press Manager, by email at anna.sundblad@swedbank.com (http://file:///R:/Staber/Corporate%20Affairs/Media%20Relations/Pressreleaser/Engelska/2015/mail%20to:anna.sundblad@swedbank.com) or telephone +46 703 21 39 95. Lunch presentation for investors and analysts in London on 17 July at 12:30 BSTGöran Bronner, CFO, and Gregori Karamouzis, head of Investor Relations, will present the report and answer questions at Carnegie, Finwell House, 26 Finsbury Square, London EC2A 1DS. The presentation is expected to end at 14:00 BST. Please register your attendance by email at ir@swedbank.com (http://file:///R:/Staber/Corporate%20Affairs/Media%20Relations/Pressreleaser/Engelska/2015/mail%20to:ir@swedbank.se) For further information please contact:Gregori Karamouzis, Head of Investor Relations, phone: +46 727-40 63 38 or gregori.karamouzis@swedbank.com   Swedbank promotes a sound and sustainable financial situation for the many people, households and companies. Our vision is to contribute to development “Beyond Financial Growth”. As a leading bank in the home markets of Sweden, Estonia, Latvia and Lithuania, Swedbank offers a wide range of financial services and products. Swedbank has over 7 million retail customers and around 600 000 corporate customers and organisations with 304 branches in Sweden and 154 branches in the Baltic countries. The group is also present in other Nordic countries, the US and China. As of 31 March 2015 the group had total assets of SEK 2 275 billion. Read more at www.swedbank.com

Georgian market leading operator Adjarabet.com adds Evolution’s full Live Casino line-up

Adjarabet now offers all of Evolution’s generic shared tables – Live Roulette, Blackjack, Baccarat, Casino Hold’em and Three Card Poker, including Immersive Roulette, Blackjack Party and VIP tables – with customers able to play the widest choice of live games on desktop, tablet and smartphone. As part of the implementation, Evolution added the Georgian language to the user interface and help pages for all of these games. Founded in 1998 and regulated by the Georgian Government, Adjarabet is firmly established as the Georgian market leader in online gaming and sports betting. It currently offers customers an extensive choice of sports betting, RNG slots, poker and table games, live casino, backgammon and skill games. The complete site is available in three languages: Georgian, English and Russian. Archil Kakhidze, Head of Sport and Casino at Adjarabet commented: “By choosing Evolution we have been able to rapidly extend and enhance our Live Casino offering. Evolution has built its reputation working alongside market leaders in many other territories, so we feel confident that we now have a powerful, flexible and scalable solution that gives us huge scope to deliver the very best for our players as we grow and develop.” Sebastian Johannisson, Head of Account Management at Evolution, added: “We are delighted to be working with Adjarabet, the clear market leader in Georgia. Their success is founded on offering their players a great choice of games, fast payouts and excellent customer service. Evolution Live Casino is a great match for Adjarabet in every way and we look forward to helping them achieve further success.”

Pandox AB (publ) enters settlement agreement with Nordic Choice Hospitality Group AS

According to the settlement agreement and the agreement with the bankruptcy estate, Pandox will receive compensation corresponding to minimum MSEK 60, which will be reported as other income Property management in the third quarter 2015. The claims have not been attributed any value in Pandox’s balance sheet. This settlement agreement concludes the legal proceeding described in the “Invitation to acquire B shares in Pandox Aktiebolag (publ)“ in page 106 “legal and arbitration proceedings”. FOR MORE INFORMATION, PLEASE CONTACT: Anders Nissen, CEO, +46 (0)70 846 02 02Thomas Backteman, IR, +46 (0)70 831 11 66 Pandox AB (publ) is required to publish this information under the Swedish Securities Market Act and/or Financial Instruments Trading Act. The information was submitted for publication on 3 July 2015 at 14:25 CET. About PandoxPandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 104 hotels with approximately 22,000 hotel rooms across eight countries. Pandox’s business is organised into Property management, which comprises 89 hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its 15 owner-occupied hotel properties. Pandox’s B shares are, as of 18 June 2015, listed on Nasdaq Stockholm.

Endomines reports encouraging gold intersections from Pampalo Deep extensions

Endomines is pleased to report results from the ongoing exploration campaign at Pampalo and other Karelian Gold Line exploration targets. The results include new very encouraging gold intersections from the Pampalo Deep Extensions including holes T-916 7.0m@12.2 g/t gold (incl. 4.0m@20.4 g/t gold) and T-917 17.0 m@3.2 g/t gold. These holes were drilled to a previously unknown structure at the Pampalo Deep Northern lens extension and indicate that there might be previously unknown high-grade lenses at Pampalo. In addition recently identified new S2-lens extension has been confirmed by the drill hole number T-910 (6.0m@5.3 g/t gold) at the level 590. The S2-lens has also been verified with drifting at the upper levels. The most interesting drill intersections are presented in a separate Exploration Report together with complete drilling result tables on the Company´s website and in the attachment. The Company will continue to explore the area once geometric conditions and development drifting allows. “We are very excited and delighted of these higher grade intersections in the previously unknown area. Our commitment to continue exploration at Pampalo and other targets has given very positive results”, comments Markus Ekberg, CEO of Endomines. The company has also commenced Base-of-till sampling in March at the NE corner of the Kuittila tonalite. By June 30th about a 930 samples have been collected from the area between Muurinsuo East and Korvilansuo, Pampalo East – Pampalo NW and Hosko North. The sampling target for 2015 is 2,000 samples. Assay results are pending. All results received by 30th June are published in the attached complete report as well as on the Company´s website. Competent Person: This statement has been controlled by Eurogeologist, MSc (Geol) Markus Ekberg acting as a Qualified Person in compliance with Fennoscandian Review Board -standards. Markus Ekberg is employed by Endomines as Chief Executive Officer and owns 180 000 shares in Endomines. For further information, please contact:Markus EkbergCEO of Endomines ABtel. +358 40 706 48 50 Alternatively, visit the Company´s home page: www.endomines.com Endomines AB discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 17:40 CEST on July 3, 2015.   About Endomines:Endomines conducts exploration and mining business along the 40 kilometer long Karelian Gold Line. Through various regulatory approvals, Endomines controls the exploration rights to this entire area. The Company’s first mine, Pampalo, started in February 2011. During 2014, Endomines initiated the production of ore from the mine in Rämepuro and is planning to start mining of the gold deposit in Hosko. The ore from satellite mines will be processed in the centrally located mill at Pampalo. The Company’s business practices and mining operations are based on sustainable principles and on minimizing the impact on the environment. Endomines applies SveMin's & FinnMin's respective rules for reporting for public mining & exploration companies. The Company has chosen to report mineral resources and ore reserves according to the JORC-code, which is the internationally accepted Australasian code for reporting ore reserves and mineral resources. Endomines vision is to participate in the future structural transformation and consolidation of the Nordic mining industry. The Company may therefore be involved in acquisitions of interesting deposits or companies, should such opportunities arise. The shares of Endomines AB are quoted on NASDAQ Stockholm under ticker ENDO and on NASDAQ Helsinki under ticker ENDOM. The Liquidity Provider in both Stockholm and Helsinki is Erik Penser Bankaktiebolag. This news release may contain forward-looking statements, which address future events and conditions, which are subject to various risks and uncertainties. The Company's actual results, programs and financial position could differ materially from those anticipated in such forward-looking statements as a result of numerous factors, some of which may be beyond the Company's control. These factors include: the availability of funds; the timing and content of work programs; results of exploration activities and development of mineral properties, the interpretation of drilling results and other geological data, the uncertainties of resource and reserve estimations, receipt and security of mineral property titles; project cost overruns or unanticipated costs and expenses, fluctuations in metal prices; currency fluctuations; and general market and industry conditions. Forward-looking statements are based on the expectations and opinions of the Company's management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking

ENVISION ACQUIRES SWEDISH WIND FARM PROJECT

“We are very excited about this acquisition as the first project investment in our European expansion and believe that it will be a great opportunity to via this wind farm demonstrate our technological ability and innovative approach”, says Felix Zhang, Executive Director and Head of International Business, at Envision.The Kafjärden wind farm has competitive cost of energy and a good fit with the intended turbine technology. It has been developed by Christer Öholm and Paula Tidefjärd who owns the land for some of the turbine positions and who will retain an ownership stake. “We are very pleased to soon see the wind farm in operation. Kafjärden is one of few strong wind farm locations in this area of the country”, says Christer ÖholmNewsec has acted as exclusive financial advisor to Christer Öholm and Paula Tidefjärd in the transaction and thereby concludes its 23rd wind farm transaction on the Swedish market since 2007.“Swedish wind power is increasingly becoming part of an international investment market attracting both financial and industrial investors. Envision’s acquisition marks the entry of a new innovative industrial company”, says Omid Ashrafi, Head of Infrastructure and Energy Newsec.Kafjärden, which is located in the municipality of Eskilstuna, will consist of Envision’s proven smart wind turbines, designed by the Global Innovation Center in Denmark and the R&D center in Shanghai, and will also leverage Envison’s strong EPC management competency. It will once commissioned be the largest Nordic wind farm owned by a China based company. Envision Energy is right now the top 3 wind turbine supplier in China. The wind farm will also be armed with the full life cycle management system consisting of the “Greenwich™” cloud platform and the Wind OS™ management system, the development of which is based on smart sensor network and cloud computing. Envision Energy now manages 10 million kilowatts of global alternative energy assets, and currently is the largest smart energy management company in the world.

Record strong earnings during first six months of the year

During the period, Fabege’s investment-property portfolio contributed to the favourable earnings through both a positive cash flow and value growth. Growth in net asset value was healthy, with EPRA NAV rising SEK 15 year-on-year to SEK 102 per share. Net lettings totalled SEK 51m in the first half year “Fabege’s focus on city district development has been successful. The recently acquired project properties from Catena in conjunction to Arenastaden match this focus well and are an exciting component in the effort for continued value generation. The market remains generally strong with high demand for sustainable modern offices in attractive locations served by trains,” says Christian Hermelin, CEO of Fabege. Fabege AB (publ) For further information, please contact:Christian Hermelin, CEO of Fabege, phone +46 (0)8-555 148 25, +46 (0)733-87 18 25Åsa Bergström, Deputy CEO and CFO, phone +46 (0)8-555 148 29, +46 (0)706-66 13 80   This constitutes information that Fabege AB (publ) may be legally obliged to publish under the Securities Market Act and/or the Financial Instruments Trading Act. The information was released for publication at 8:02 pm (CET) on 6 July 2015. Fabege AB (publ) is one of Sweden’s leading property companies focusing mainly on letting and managing office premises and property development. Fabege owns properties with a carrying amount of SEK 36.4bn. The portfolio is concentrated in the Stockholm region and has an annualised rental value of SEK 2.2bn and a lettable area of 1.1m sqm. Fabege’s shares are listed on Nasdaq OMX Stockholm, Large Cap segment.

Classic Cars join Classic Engines on the North Yorkshire Moors Railway

There will be classic engines on the rails, and classic cars by the side this weekend (11 & 12 July 2015), when stations along the North Yorkshire Moors Railway turn their car parks over to vintage vehicles of all shapes and sizes! Each day, Levisham, Goathland and Grosmont stations will play host to over 150 classic cars and vehicles, from Ford Capris to classic Jaguars, and Morris Minors to vintage Bentleys, where visitors can relax with a refreshing pint from the real ale bar as they continue their exploration of the classics of motoring. “Many of these vehicles are works of art in their own right, so even if you are not a huge fan of historic cars, they are wonderful to look at – each lovingly cared for, and many of them painstakingly restored, by their owners,” comments marketing manager, Danielle Ramsey.  “For enthusiasts, this is an amazing day out with our trains providing a fantastic way of travelling between the three main venues!” Indeed, passengers boarding the train at Pickering will also enjoy a treat at the station, with a 1946 Leyland Titan double decker bus and a small collection of classic cars on display outside as visitors arrive at the historic railway’s terminal. At Levisham, passengers will be able to relax as they enjoy their liquid refreshment to the sounds of Jive Express, who will be performing in the paddock next to the platform on both days from 12 noon until 4.00pm.  Admission is free for those with a valid travel ticket, or just £5 for those reaching the station via an alternative means of transport. More details and the full timetable of rail services is available online at www.nymr.co.uk, with pre-booking strongly recommended as services can be busy during the summer months.  Day rover tickets cost from £20 for adults, £17 for concessions and just £10 for children, with family tickets (two adults and up to four children) available for just £44.00 for the route between Pickering and Grosmont.  Under 5s travel free. Bookings can be made online by visiting www.nymr.co.uk or by calling 01751 472508. ENDS Hi-res images can be downloaded by following the links at the bottom of this email, or by visiting http://news.cision.com/north-yorkshire-moors-railway For further media information or photographs, please contact: Jay Commins Pyper York Limited Tel:         01904 500698 Email:    jay@pyperyork.co.uk

CMS and AMA Announce Efforts to Help Providers Get Ready For ICD-10

WASHINGTON - July 6, 2015 - With less than three months remaining until the nation switches from ICD-9 to ICD-10 coding for medical diagnoses and inpatient hospital procedures, The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) are announcing efforts to continue to help physicians get ready ahead of the October 1 deadline. In response to requests from the provider community, CMS is releasing additional guidance that will allow for flexibility in the claims auditing and quality reporting process as the medical community gains experience using the new ICD- 10 code set.Recognizing that health care providers need help with the transition, CMS and AMA are working to make sure physicians and other providers are ready ahead of the transition to ICD-10 that will happen on October 1. Reaching out to health care providers all across the country, CMS and AMA will in parallel be educating providers through webinars, on-site training, educational articles and national provider calls to help physicians and other health care providers learn about the updated codes and prepare for the transition.“As we work to modernize our nation’s health care infrastructure, the coming implementation of ICD-10 will set the stage for better identification of illness and earlier warning signs of epidemics, such as Ebola or flu pandemics.” said Andy Slavitt, Acting Administrator of the Centers for Medicare and Medicaid Services. “With easy to use tools, a new ICD-10 Ombudsman, and added flexibility in our claims audit and quality reporting process, CMS is committed to working with the physician community to work through this transition.” “ICD 10 implementation is set to begin on October 1, and it is imperative that physician practices take steps beforehand to be ready,” said AMA President Steven J. Stack, MD. “We appreciate that CMS is adopting policies to ease the transition to ICD-10 in response to physicians’ concerns that inadvertent coding errors or system glitches during the transition to ICD-10 may result in audits, claims denials, and penalties under various Medicare reporting programs. The actions CMS is initiating today can help to mitigate potential problems. We will continue to work with the administration in the weeks and months ahead to make sure the transition is as smooth as possible.” The International Classification of Diseases, or ICD, is used to standardize codes for medical conditions and procedures. The medical codes America uses for diagnosis and billing have not been updated in more than 35 years and contain outdated, obsolete terms.The use of ICD-10 should advance public health research and emergency response through detection of disease outbreaks and adverse drug events, as well as support innovative payment models that drive quality of care. CMS’ free help includes the “Road to 10 (http://www.roadto10.org/)” aimed specifically at smaller physician practices with primers for clinical documentation, clinical scenarios, and other specialty-specific resources to help with implementation. CMS has also released provider training videos that offer helpful ICD-10 implementation tips. The AMA also has a broad range of materials available to help physicians prepare for the October 1 deadline. To learn more and stay apprised on developments, visit AMA Wire (http://www.ama-assn.org/ama/ama-wire/blog/ICD-10/1). CMS also detailed its operating plans for the ICD-10 implementation. Upcoming milestones include:  · Setting up an ICD-10 communications and coordination center, learning from best practices of other large technology implementations that will be in place to identify and resolve issues arising from the ICD-10 transition. · Sending a letter in July to all Medicare fee-for-service providers encouraging ICD-10 readiness and notifying them of these flexibilities. · Completing the final window of Medicare end-to-end testing for providers this July. · Offering ongoing Medicare acknowledgement testing for providers through September 30th. · Providing additional in-person training through the “Road to 10” for small physician practices. · Hosting an MLN Connects National Provider Call on August 27th. In accordance with the coming transition, the Medicare claims processing systems will not have the capability to accept ICD-9 codes for dates of services after September 30, 2015, nor will they be able to accept claims for both ICD-9 and ICD-10 codes. Also, at the request of the AMA, CMS will name a CMS ICD-10 Ombudsman to triage and answer questions about the submission of claims. The ICD-10 Ombudsman will be located at CMS’s ICD-10 Coordination Center. # # # Editor’s Note:  AMA President Steven J. Stack, M.D. offers a perspective article on today’s announcement in this morning issue of AMA Wire (http://www.ama-assn.org/ama/ama-wire/post/cms-icd-10-transition-less-disruptive-physicians). Contacts:CMS Media Relations, (202) 690-6145 | CMS Media InquiriesAMA Media Relations, (312) 464-4430 | AMA Media Inquiries (http://www.ama-assn.org/ama/pub/news/for-media/media-inquiries.page)

EMAS OFFSHORE GAINS WIN MOMENTUM WITH THREE CONTRACT AWARDS WORTH US$24 MILLION

EMAS Offshore Limited (“EMAS Offshore” or “the Group”), an established offshore services provider offering offshore support, accommodation, construction and production services to the oil and gas industry, today announced that it has secured three new awards for charters with oil majors in West Africa and Thailand valued at more than US$24 million (including options). In West Africa, EMAS Offshore’s Anchor Handling Tug and Supply (“AHTS”) vessel will be providing sea transportation services that include towing, performing anchor handling and positioning of rigs and other floating structures for an oil major. Over in the Gulf of Thailand, EMAS Offshore’s other two contracts are with EMAS Energy, an entity that belongs to the Well Services division of Ezra Holdings Limited. One of the contracts is part of an integrated and comprehensive solution for an oil major in Thailand, and is a charter for a Platform Support Vessel, while the other contract is for the provision of an AHTS vessel for a national oil company, both awarded after a competitive tendering process. The scope of work includes the provision of accommodation, towing, anchor handling and logistics support for oil and gas production platforms, and collectively is worth some US$12 million. Mr. Jon Dunstan, EMAS Offshore’s Chief Executive Officer, said: “We have a distinct advantage of being able to deploy vessels globally. I am delighted to see that our strategy of focusing our efforts in West Africa where offshore activities remain healthy is paying off. “Additionally, the wins in Thailand demonstrate the synergy we have within the EMAS brand to deliver integrated solutions, and is yet another competitive advantage we can leverage, especially amidst market volatility.” The average contract duration for the contracts is approximately 1.1 years and the charters are expected to commence in Q4 FY2015.

EMAS OFFSHORE REPORTED NET PROFIT OF US$5.2 MILLION IN 3QFY15

EMAS Offshore Limited (“EMAS Offshore” or the “Company”), reported net profit of US$5.2 million in the three months ended 31 May 2015 (“3QFY15”), an increase from the US$0.2 million in the corresponding period. Revenue was US$59.2 million, a decrease of 15% from the same period last year. The higher net profit was supported by robust contributions from the Offshore Production Services division, which comprised two Floating Production, Storage and Offloading (“FPSO”) vessels. This was offset by weakness in the Platform Support Vessel (“PSV”) and small Anchor Handling, Towing and Supply Vessel (“AHTS”) business segments. Mr Jon Dunstan, EMAS Offshore’s Chief Executive Officer, said: “Amidst the challenging market environment and oil price volatility, we continue to take steps to reduce costs, implement initiatives to improve operational efficiency and increase focus on vessel utilisation.” In the Offshore Support and Accommodation Services division, utilisation rate was down to approximately 70% for the quarter, largely due to relatively weak demand for small AHTS and shallow water PSV, which resulted in a utilisation rate of 74% for the nine months ended 31 May 2015. However, the Company continues to see sustained demand in the larger AHTS segment, where utilisation rate remains high at above 90%, as vessels of this category are required in the Asia-Pacific and West Africa regions to support various offshore activities. In the Offshore Production Services division, the two FPSOs continue to perform well, with high operational uptime of more than 98%. The FPSOs are both on multi-year contracts and operating in production fields with good long-term production rates and profiles. This has added resilience to the Company’s financial performance despite volatility in the oil price and operating environment. The Company recently announced contracts wins valued at approximately US$30 million across West Africa and Asia Pacific, and today, separately announced an additional US$24 million worth of contract awards in the same regions. “Looking ahead, the short-term outlook for the industry still remains challenging, but we believe that our strategy of focusing our capabilities and maintaining operational excellence in key geographical areas will hold us steady,” said Mr Dunstan. “We will continue to leverage synergies within the EMAS brand to create comprehensive and integrated solutions for our clients.”

Reminder of expiry of subscription period in the Subsequent Offering

Oslo, 7 July 2015 Reference is made to the stock exchange announcement by NEL ASA (the "Company" or "NEL") on 24 June 2015 regarding the approved prospectus and start of subscription period in the Subsequent Offering.        The subscription period in the Subsequent Offering expires 7 July 2015 at 16:30 CET. Subscription rights that are not used to subscribe for Offer Shares before the end of the Subscription Period will lapse without compensation and consequently be of no value. Each subscription right gives the right to subscribe for and be allocated one Offer Share. Over-subscription is allowed. The Prospectus together with the Subscription Form is available at www.nel-hydrogen.com and www.carnegie.no, and is also available free of charge at the business offices of the Company and Carnegie. Norwegian investors with a VPS account can in addition subscribe for Offer Shares online at www.carnegie.no. For further information, please contact: Lars Christian Stugaard Acting CEO +47 23 01 49 06 / +47 47 63 05 22 lars.christian.stugaard@nel-hydrogen.com Important information: The release is not for publication or distribution, in whole or in part directly or indirectly, in or into Australia, Canada, Japan or the United States (including its territories and possessions, any state of the United States and the District of Columbia). This release is an announcement issued pursuant to legal information obligations, and is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. It is issued for information purposes only, and does not constitute or form part of any offer or solicitation to purchase or subscribe for securities, in the United States or in any other jurisdiction. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. The Company does not intend to register any portion of the offering of the securities in the United States or to conduct a public offering of the securities in the United States. Copies of this announcement are not being made and may not be distributed or sent into Australia, Canada, Japan or the United States. The subscription or purchase of shares in the Company is subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company nor the Manager assumes any responsibility in the event there is a violation by any person of such restrictions. The distribution of this release may in certain jurisdictions be restricted by law. Persons into whose possession this release comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. The Manager is acting for the Company and no one else in connection with the Subsequent Offering and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to any other matter referred to in this release. Forward-looking statements: This release and any materials distributed in connection with this release may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the Company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

IFS acquires VisionWaves

VisionWaves provides operational intelligence software that helps customers accelerate their strategy realization and boost business performance. Its unique model-driven, top-down methodology not only provides leaders and decision makers with a clear picture of their business’s performance in real-time, but also enables them to take action and continually improve operations and business models. By combining VisionWaves with IFS’s industry-focused solutions, customers can benefit from: · VisionWaves’ ability to map, monitor, and manage end-to-end business processes across multiple business units, data sources and applications. This builds in an ‘at-a-glance’ understanding of how performance affects business strategy and proactively initiating actions. · The two solutions’ ability to enable customers to accelerate strategy realization and boost business performance by providing a common operational picture and improving business process performance in a truly integrated way. VisionWaves was founded in 2000 and has its headquarters in Zeist, the Netherlands, with a sales office in the U.S. The company has 30 employees and generated €4.9 million in revenue and an adjusted EBITDA-margin of 17% (last 12 months up to May 2015, unaudited). The Company has successfully implemented its solution at large multinational customers in the following industries:  Aerospace & Defence, Transportation, Mining, Engineering & Construction, Energy & Utilities, Public Sector, Finance, and Healthcare. VisionWaves has over 30 blue chip customers including Emirates, Qinzhou Power Plant/SDIC, Chilean Air Force, Dodsal, Lumina Mining, Dutch MoD and National Police, ING, Achmea and Rabobank. Well established partnerships exists with several system integrators incl. Capgemini, Accenture and Serco. Alastair Sorbie, IFS CEO said, “With the acquisition of VisionWaves, IFS can be seen as executing on its stated strategy for growth by investing in one of the fastest growing sectors for enterprise applications. IFS’s ambition is to enable our customers to become more agile and increase their ability to accelerate their strategy realization. VisionWaves will strongly contribute to this and in addition complement IFS’s partner eco-system strategy very well; system integrators are highly attracted to the operational intelligence and business performance improvement value proposition.” IFS expects that there will be a limited positive earnings impact from the acquisition in 2015.